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The central dogma of molecular biology forms the most basic (and fundamental) 
paradigm of how life operates. Despite its elegant simplicity, scientists are still 
uncovering enigmas of the central dogma - which has been shaped throughout billions of 
years of the Darwinian process. Even though the core concepts of the central dogma have 
largely been untouched by evolution (the universality of the genetic code, amino acid 
utilization, DNA/RNA base identity) scientific advances have shown that these 
fundamental properties can be altered dramatically. This implies the architectures of life 
are pliable and likely the result of extreme optimization and fine tuning of semi-random 
events that took place soon after the origin of life.  
Reengineering the parameters of life offers a unique way of testing evolutionary 
processes and perceived optimality of its components. Naturally, coaxing proteins and 
nucleic acids to function in an unnatural fashion is difficult. Development of techniques 
to enable these changes has relied heavily on the exploitation of water-in-oil emulsions 
(or, in vitro compartmentalization), which allows directed evolution at the single cell or 
even single molecule level. In particular, compartmentalized partnered replication (CPR) 
is a dual mode selection technique, coupling the in vivo functionality of a gene with the in 
vitro amplification via emulsion PCR. The CPR technique has enabled the development 
of synthetic promoter recognition by T7 RNA polymerase, unnatural amino acid 
 viii 
incorporation by aminoacyl tRNA synthetase engineering, genetic code reassignment 
through tRNA evolution, and transcriptional regulation using repressors with novel 
allosteric effector molecules and operator binding sites. Using a similar technique, the 
template recognition of an Archaeal DNA polymerase was altered such that the 
polymerase utilizes both DNA and RNA templates with similar efficiencies. This resulted 
in a reverse transcriptase that can functionally proofread on RNA templates.   
These technologies will continue to play a pivotal role in the future development 
of particular aspects of the central dogma. As certain steps in this process are tweaked to 
have alternative functionalities and combined together, the gap between natural life and 
synthetically modified life widens and gives the Darwinian process of evolution new 
areas to explore.  
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 The molecular basis of life on Earth relies on the information flow between DNA, 
RNA, and proteins – which was so elegantly postulated by Francis Crick in the central 
dogma of molecular biology. This framework accounts for the general under-workings 
behind organismal phenotype and genetic heredity. It describes the residue by residue 
transfer of sequential information; how one type of molecule becomes another and how 
sequence information is passed down through the generations of evolutionary time.  
 Since this framework was put forth, researchers have begun to probe the limits of 
the central dogma. The molecular machines driving the transfer of sequence information 
can sometimes utilize non-natural substrates. Additional molecular engineering of these 
proteins and nucleic acids can further the reach of the substrate analogs utilized. As time 
has gone on, more sophisticated in vivo and in vitro screening and selection 
methodologies have begun to create the tools necessary to create alternative central 
dogmas using synthetic substrates.    
THE CENTRAL DOGMA IN NATURE 
Nucleic acid replication 
 Watson and Crick’s model for the structure of DNA was profound because it 
provided a mechanism for heritability (Watson and Crick, 1953). One half of the double 
stranded duplex provides the information to synthesize the other half. This mechanism 
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was elegantly demonstrated by Meselson and Stahl, who proved that nucleic acid 
replication is semiconservative (Meselson and Stahl, 1958). Since then, the biomolecules 
behind the replication have been elucidated, and while the replication machinery is 
complex the core component is the protein polymerase (Leman and Noguchi, 2013).  
 In vitro reconstitutions of the replication machinery show that polymerization can 
occur simply given a polymerase, a hydroxyl group to prime the initiation of the 
complement strand, and substrate deoxynucleotide triphosphates (Lehman et al., 1958). 
Since this discovery, the most pervasive example of nucleic acid replication systems is 
the polymerase chain reaction (PCR) (Mullis and Faloona, 1987). In PCR, priming 
oligonucleotides that bind to each strand of a target region (i.e. “facing each other”) 
undergo sequential rounds of primer extension that, in effect, will create another template 
for the opposing primer oligonucleotide - ultimately resulting in exponential 
amplification of the specified DNA sequence. This technique has revolutionized the 
whole of biology, giving the ability to not only amplify small amounts of DNA but allow 
it to be put together in any imaginable way. 
 Since its inception, the PCR technique has undergone massive improvements. 
Perhaps the most important technical improvement came when thermostable DNA 
polymerases were introduced (Saiki et al., 1988). This allowed polymerase enzymes to 
remain active after heat denaturation of the template DNA. Further advances were made 
when error-correcting DNA polymerases were used in the PCR reaction - increasing 
replication fidelity. Archaeal Family-B polymerases (the organism’s replicative 
polymerase) contain an editing domain (3’-5’ exonuclease) that is stimulated upon base 
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misincorporation (Fidalgo da Silva and Reha-Krantz, 2007). Adding components of the 
replication holoenzyme, namely the PCNA clamp, has also been shown to improve PCR 
by increasing the processivity of the polymerase complex (Kitabayashi et al., 2002). 
 In addition to DNA to DNA replication, RNA has been shown to complete the 
same replication cycle. These are generally considered a special case for the central 
dogma, and are normally only found in small viral elements. The most well studied 
example of this is the Q-beta replicase (Haruna et al., 1963). This bacteriophage 
polymerase is responsible for the replication of the viral RNA genome, by iterative 
copying of the plus and minus strands. This RNA replicase has been used for 
biotechnology applications, but template sequence requirements limit its utility (Cahill et 
al., 1991). Interestingly, the Q-beta replicase was used for some of the first in vitro 
selection experiments by Sol Speigelman which demonstrated that RNA molecules could 
evolve to gain new functions (Mills et al., 1967).  
 In addition to protein-based nucleic acid replication, there have been significant 
advances towards the understanding of nucleic acid polymerization in a prebiotic world. 
Because the components of the prebiotic world are evolutionarily extinct, the best way to 
understand it is to reconstruct its key elements. For instance, ribozymes can be selected in 
vitro from large randomized pools of RNA and have been shown to perform a wide 
variety of chemistries (Walter and Engelke, 2002). Most impressively, the Bartel lab 
created the first ribozyme-based polymerase (Johnston et al., 2001). This polymerase is 
capable of template directed RNA polymerization, which provides the means of a 
prebiotic world to replicate its genetic material and begin Darwinian evolution. Since its 
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inception, the ribozyme polymerase has undergone numerous improvements by utilizing 
emulsion-based directed evolution techniques (Wochner et al., 2011; Zaher and Unrau, 
2007). The first versions of the polymerase could only extend a primer oligonucletide 
several bases, but after extensive evolution and engineering it has been demonstrated to 
synthesize over 200 bases (the length of the ribozyme) (Attwater et al., 2013). The 
demonstration of a ribozyme polymerase, and eventually of a simple self replicating 
entity, provides the simplest possible mechanism of the central dogma. 
 Our ability to control nucleic acid polymerization in a controlled fashion has 
revolutionized biology. The tools invented from these fundamental biological inquiries 
have enabled de novo DNA synthesis, cloning, diagnostic, therapeutic, sequencing, and 
evolutionary insights. Into the future, polymerases will play a pivotal role especially in 
applications for next-generation DNA and RNA sequencing technologies. 
Transcription 
 Transcription plays a pivotal role in biology, by acting as the messenger between 
DNA and the translational apparatus. Cellular transcription is unique from the nucleic 
acid replicators mentioned above, in that they do not require a complementary primer to 
initiate polymerization. The de novo synthesis of RNA transcripts is carried out upon the 
transcription machinery’s recognition of a promoter sequence (Chamberlin et al., 1970). 
The process of promoter recognition is vastly different between replication complexes, 
and between prokaryotes and eukaryotes. Promoter initiation can be influenced by a wide 
range of factors, including: ancillary proteins that bind upstream or downstream in the 
DNA, the availability of DNA binding sites by competitive binding of other proteins or 
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sequestration into chromatin structures, and the cascade of gene expression leading up to 
transcription which can be influenced by small molecules or signaling pathways (Madan 
Babu, 2003).  
 While the transcription machinery is integral for the production of messenger 
RNAs, the role of RNA transcripts extends far beyond this in the cell. Non-coding RNAs 
have a variety of functional roles in cells. Perhaps the most famous, and integral to the 
central dogma, is the ribosome and tRNAs that decode mRNA messages (Ramakrishnan, 
2002). Certain RNAs can serve to modulate the functional readout, perhaps most 
famously in self-splicing introns for tRNA maturation or in the splicosomal ribonucleo-
protein complex which removes introns from coding RNAs (Cech, 1990; Will and 
Luhrmann, 2011). Other non-coding RNAs have gained much attention recently, the 
discovery of the CRISPR/CAS system has revolutionized biotechnology by allowing 
specific cleavage of DNA sequences given a complementary guide RNA sequence (Jinek 
et al., 2012).  
 The precise control of gene expression is heavily reliant on the regulation of 
transcription. In bacteria, this is controlled by transcription factors which bind to DNA 
sequences recruiting or competing for transcription machinery binding. In biosynthetic 
operons, expression is regulated heavily by positive or negative feedback. DNA binding 
proteins that are allosterically regulated by the products of the pathway will alter 
conformational states to reflect the internal parameters of the cell (Rogers et al., 2015).   
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Reverse Transcription 
 The unidirectional view of the central dogma was turned on its head in 1970 when 
Temin and Baltimore discovered the first reverse transcriptases in mammalian RNA 
viruses (Baltimore, 1970; Temin and Mizutani, 1970). Since the RT’s discovery, it has 
been found across the domains of life (Xiong and Eickbush, 1990). The RT was initially 
thought to have arisen early in life’s history serving to convert RNA to more stable DNA 
genomes (Darnell and Doolittle, 1986). Since then, it has found a number of different 
roles such as telomere maintenance, retrotransposon copying and insertion, and viral 
replication (Boeke and Stoye, 1997). The conversion of an RNA molecule into DNA has 
enabled significant advances in biology, most importantly enabling the conversion of 
mature RNAs into cDNA. However, the RTs use in biotechnology has been limited by 
their poor stability and lack of a proofreading domain. 
Translation 
 The decoding of mRNAs into proteins is of paramount importance to cells, as 
estimates put it at a quarter of the cells total mass. The sequential transfer of information 
is determined by two factors: the step-by-step decoding of an mRNA on the ribosome by 
codon-anticodon interactions, and less appreciated, the specificity of the aminoacyl tRNA 
synthetase for its cognate tRNA. The decoding architecture is represented by the genetic 
code, which reads mRNAs in triplets and in some rare cases quadruplets. Since there are 
four possible RNA bases, a triplet code represents the near universal 64-term codon table. 
This universality is not trivial, and points towards an evolutionarily ancient common 
ancestor that preserved this code even billions of years ago (Woese, 1998). Due to this 
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surprising fact, DNA sequences from divergent organisms (such as H. sapiens and E. 
coli) can be translated in both hosts to create functional proteins. Although the genetic 
code is shared even among distant organism, there are many examples of alternative 
codes, even within human mitochondria.  
 As mRNAs are decoded on the ribosome, they move through three base intervals 
creating peptide bonds between aminoacylated tRNAs in the A and P sites of the 
ribosome (Steitz, 2008). tRNAs with the corresponding anti-codon sequence are shuttled 
to the ribosome by EF-Tu, and the sequential addition of amino acids is completed by a 
number of high energy reactions as the ribosome translocates across the mRNA. Upon 
reaching a stop signal (such as an amber codon), a release factor will bind to the stop 
codon and signal the ribosome complex to dissociate – terminating peptide synthesis.  
 The decoding of mRNAs is perhaps the most error prone process of the central 
dogma, making errors roughly 1 in every 1,000 amino acids (Loftfield and Vanderjagt, 
1972). One possibility for this high error rate could be the incorrect aminoacylation of 
tRNAs by the synthetases, but studies have demonstrated its contribution to be minor, as 
the enzymatic aminoacylation of tRNAs only makes errors roughly 1 in 106 catalytic 
events (Söll, 1990). However, this is largely dependent on the specificities of tRNAs to 
their cognate synthetases, as tRNA identity elements can cross-react. The rate at which 
certain codons contain errors is highly variable suggesting misincorporation is partially 
based on inappropriate binding of noncognate tRNAs which may be driven by tRNA 
competition of the A-site (Kramer and Farabaugh, 2007). Some recent evidence also 
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suggests that EF-Tu performs an amino acid identity check by binding both the amino 
acid and tRNA elements (Schrader et al., 2011).  
ALTERATIONS TO THE CENTRAL DOGMA  
 Through engineering efforts the central dogma has been shown to be pliable, 
accepting unnatural substrates (Fig. I.1). Here, the altered specificity of some of the 
systems is discussed which shows that even highly conserved proteins and nucleic acids 
have the potential to utilize novel substrates. This begs the question, how far can we 
deviate from what nature left us? 
 Nucleic acid polymerases have been demonstrated to utilize both modified 
substrates and modified templates. Originally, investigations into polymerase mutants 
capable of utilizing modified substrates were performed to improve sequencing 
techniques by enhancing a polymerases’ ability to incorporate chain terminators or dye 
labeled nucleotides (Vander Horn et al., 1997). Further investigations probed the 
substrate specificity of Archaeal Family-B polymerases by sequence alignments of 
conserved regions involved in substrate discrimination in the active site (Joyce and Steitz, 
1995) . Small scale screens of mutations in these regions relaxed the substrate specificity 
improving incorporation of dideoxyribonucleotides and even ribonucleotides (Gardner 
and Jack, 1999). This engineered polymerase (termed Therminator) contained mutations 
Y409G and A488L which are implicated as a steric gate - blocking ribonucleotide 
incorporation and relaxing nucleotide selectivity, respectively. Additionally, the 
Therminator polymerase could incorporate threose nucleic acids (TNAs), which only 
have a 4 carbon sugar backbone (Ichida, 2005).  In fact, it was later shown that in 
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combination with several additional mutations (E664K and V93Q) the Archaeal polB 
enzyme could effectively incorporate RNA to the point where mRNAs longer than one 
kilobase could be polymerized (Cozens et al., 2012). 
 While the Therminator polymerase was discovered based on small scale screens 
of conserved motifs of Archaeal polB, more drastic changes needed to be made to 
improve the incorporation of modified bases and allow the incorporation of even more 
divergent base analogs. The interactions made between polymerases and the substrates, 
templates, and nascent strand are extensive, making rational mutagenesis nearly 
impossible, and library design challenging. A number of research groups have developed 
selection methodologies that enable the high throughput scanning of mutations for a 
desired functionality. Various in vivo and in vitro approaches have been developed to 
tackle this problem (Holmberg et al., 2005). The two most successful in vitro strategies 
have relied upon phage display technologies and emulsion based compartmentalized self 
replication (CSR; discussed below). In phage display selections, polymerases are 
physically encoded into the gene sequence of M13 gene p3 (Jestin et al., 1999). Primer-
template complexes are tethered to the phage by covalently cross-linking, and nucleotide 
addition can be selected by incorporation of a biotinylated nucleotide followed by affinity 
pull-down of the phage (Xia et al., 2002). Using this basic methodology DNA 
polymerases have been engineered to incorporate ribonucleotides, including modified 
ribonucleotides such as 2’-O-methyl RNA (Fa et al., 2004).  
 Building on top of this work, researchers have become interested in more and 
more chemically divergent substrates. For instance, Kool demonstrated that hydrophobic 
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base analogs, geometrically similar to purines and pyrimidines, could be used as 
substrates by natural polymerases (Schweitzer and Kool, 1995). These findings point 
towards geometry of base pairs being an important factor in polymerization, and not 
specific base hydrogen bonding . The Hirao and Romesberg laboratories have also 
created nucleic acid analogs based on hydrophobic base composition, but unlike the Kool 
bases, have diverged structurally (Berger et al., 2000; Hirao et al., 2006). The Benner 
laboratory has also constructed artificial bases, but uniquely these can have altered 
hydrogen bonding between bases (Yang et al., 2006). The rearranged hydrogen bonding 
pairs between nucleobases should give more specificity than the simple geometric 
packing present in the other unnatural base pairs (UBPs). Most experiments with the 
UBPs have tested polymerization with single UBP addition. Most natural polymerases 
utilized for their incorporation struggle with the successive polymerization of these bases, 
presumably because the altered conformation of the resulting duplex causes polymerase 
stalling (Lutz et al., 1999). Even under optimized conditions, the fidelity of these 
reactions has been quite limited, making errors roughly 1 in 100 bases incorporated 
(Malyshev et al., 2012; Yang et al., 2011).   
 Recently it has been shown that UBPs can be both transported into E. coli cells, as 
well as, incorporated during episome replication by the endogenous polymerase 
machinery (Malyshev et al., 2014). This technology is in its infancy and even with 
heavily optimized conditions the UBP sequence is lost within several generations. But, 
this provides an optimistic outlook on the use of UBPs into the future. Most intriguingly 
if UBP systems could be stably used in vivo, being utilized for both DNA replication and 
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transcription, then synthetic mRNA and tRNAs could be made with a third base pair. 
This would expand the number of usable codons to 216, as compared with the 64 in the 
standard genetic code (Thyer and Ellefson, 2014). This would greatly enable efforts to 
expand the genetic code with nonstandard amino acids by creating new codons for 
additional amino acids instead of competing with the amber codon for incorporation. The 
widespread use of UBPs across the cell may be challenging. The Romesberg bases are 
hydrophobic in nature, and their replication has caveats in vitro (Lavergne et al., 2013). It 
will remain to be seen if large stretches of hydrophobic bases will be able to be 
polymerized, as there is no additional specificity enforced by hydrogen bond pairs. For 
widespread use across a genetically augmented cell, the rearranged hydrogen bonding of 
Benner bases may provide the specificity needed. However, most modifications to the 
nucleotides are not as forgiving and have required engineering and in vitro selection 
methods to improve their function with unnatural nucleotides (Chen and Romesberg, 
2014).  
 Transcriptional machinery can also be engineered to utilize substrates outside of 
the central dogma. This work has focused mainly on the incorporation of modified 
nucleotide triphosphates instead of modified template recognition. This field is vastly 
underexplored due to the lack of a directed evolution methodology that can directly select 
for unnatural nucleotide incorporation. Selection methodologies have instead relied upon 
selections for wild-type function followed by screening of the mutant libraries for desired 
function (Holmberg et al., 2005). Most directed evolution efforts have relied heavily 
upon use of the RNA polymerase from T7 bacteriophage (T7 RNAP). This polymerase is 
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used widely because it is a monomeric enzyme (not requiring accessory factors) and it 
recognizes a short well defined promoter sequence (Milligan et al., 1987). The crystal 
structure of T7 RNA polymerase has defined the active site for nucleic acid 
polymerization (Cheetham et al., 1999), and mutations were subsequently identified that 
relax substrate specificity (Brieba and Sousa, 2000). These mutations, namely Y639F and 
H784A, render the polymerase capable of a minor amount of polymerization with fluoro-, 
amine-, deoxy-, and 2’O-methyl modified NTPs. A directed evolution approach 
identified further positions and mutations to allow increased incorporation efficiencies 
(Chelliserrykattil and Ellington, 2004). This approach relied on an autogene self-
replication system to identify active polymerases, which were then screened for activity 
with modified substrates. The functional selection in vivo selection followed with in vitro 
screening is a valid approach for identifying mutants, but requires much work on the 
backend to screen the variants. In addition the libraries almost certainly must be targeted 
and well defined, preventing exploration of mutations which may be critical to unnatural 
nucleotide addition but are not predicted from the structural or phylogenetic data. 
 Modification of the genetic code has been a longstanding goal in synthetic 
biology. Particularly, the concept of adding new amino acids to the code is an intriguing 
one. Nonstandard amino acids (NAAs) are phenomenal tools for understanding and 
engineering proteins particularly by aiding the determination of x-ray crystallography 
(Sakamoto et al., 2009), the creation of orthogonal cross linking reagents (Deiters and 
Schultz, 2005; Zhang et al., 2002), the direct incorporation of post translational 
modifications (Neumann et al., 2009), and the incorporation of photo-reactive side groups 
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to active gene function upon light induction (Hino et al., 2005). Additionally, expanded 
genetic codes are capable of increasing the fitness of an organism by proving novel 
chemistry (Hammerling et al., 2014).  
 Altering the genetic code by incorporation of nonstandard amino acids was first 
demonstrated by using global replacement strategies. In a brilliant experiment by Wong, 
tryptophan auxotrophs of B. subtilis were grown on 4-fluorotryptophan, a tryptophan 
analog, in the absence of L-tryptophan (Wong, 1983). Because the tryptophan aminoacyl 
tRNA synthetase could utilize the 4-fluorotryptophan, global replacement of tryptophan 
for the NAA occurred. Initially this lowered the fitness of the organism, which is 
unsurprising considering the amino acid substitution would alter the entire proteome. 
After several serial passages a strain was identified that not only utilized the tryptophan 
analog, but preferentially grew on it. This was a significant finding - it demonstrated that 
the genetic code is not a stagnate entity but could be modified to contain amino acids not 
found naturally. 
 While the Wong strain was evolved to utilize a tryptophan analog, this organism 
still had a twenty amino acid code – with a rare amino acid swapped for a structurally 
very similar one. To truly expand the genetic code, a codon would have to be reassigned 
to allow the incorporation of a 21st amino acid. The amber codon (UAG) has been 
utilized for almost all genetic code expansion experiments because it is the rarest codon is 
most organisms. Since it is the rarest codon, it is the least likely to have considerably 
negative effects across the proteome of the host. Examples of stop codon suppressors can 
be found throughout nature, and are postulated to be important for genome evolution by 
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facilitating the creation of fusion proteins after gene duplication (Wong et al., 2008). In 
addition to having a free codon to utilize for incorporation of a NAA, an orthogonal 
tRNA:synthetase pair is needed. Orthogonal pairs are simply defined as a tRNA that will 
not react with any of the host’s synthetases, and concurrently, a synthetase that will not 
aminoacylate endogenous host tRNAs. Orthogonal pairs are typically transplanted from 
distantly related organisms in hopes that the components will not cross-react when placed 
in the intended host organism. For instance, the first demonstration of this concept used 
an E. coli tyrosyl tRNA:sythetase pair to suppress amber codons in S. cerevisiae  
(Edwards and Schimmel, 1990). Once an orthogonal pair has been established, mutations 
to the amino acid binding pocket can be made without any fitness effects to the host 
organism. Pioneering efforts from Peter Schultz’s lab have utilized orthogonal tRNA 
synthetases to site specifically incorporate dozens of NAAs (Liu and Schultz, 2010). 
Basic variations of this theme have been successful, allowing the incorporation of 
specific NAAs in bacteria (Wang et al., 2001), yeast (Chin et al., 2003), mammalian cells 
(Liu et al., 2007), and even nematodes (Greiss and Chin, 2011).  
 By far the trysoyl tRNA Synthetase from M. jannaschii has been the most utilized 
orthogonal pair for genetic code expansion. The synthetase lacks an anticodon 
recognition domain, which allowed the swapping of the tRNA anticodon to enable amber 
codon suppression – with minimal effects to the catalytic activity of amino acid charging 
(Steer and Schimmel, 1999). Some cross reactivity with endogenous machinery was 
observed as determined by amber suppression activity solely in the presence of the tRNA 
(Wang et al., 2000). This was overcome by randomization of residues in the tRNA using 
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an in vivo negative and positive selection scheme. In this scheme, cross-reactive tRNA 
variants (in the absence of the cognate synthetase) will cause amber suppression of a 
toxic gene - negatively selecting these variants. A subsequent positive selection is 
performed with the cognate synthetase which will allow cells to survive by the amber 
suppression of an antibiotic resistance marker. Using this system, tRNAs with increased 
orthogonality were selected (Wang et al., 2001). This same positive and negative 
selection approach can be used to engineer the synthetase to specifically incorporate 
NAAs. Randomization of the amino acid binding pocket could alter the substrate 
specificity to charge the cognate tRNA with a novel amino acid. By negatively selecting 
the library variants in the absence of the desired amino acid, synthetases that incorporate 
a standard amino acid will produce a toxic gene. Performing positive selection in the 
presence of the desired amino acid will allow the amber suppression of a resistance gene. 
By iterative cycling between positive and negative selection, synthetases which are 
specific for the desired amino acid are enriched in the population. Using this approach, 
NAAs with many functional groups have been incorporated into proteins using the M. 
jannaschii pair including: ketones (Wang et al., 2003), hydroxyl-amines (Xie and 
Schultz, 2006), thioester (Xie and Schultz, 2006), alkyne (Deiters and Schultz, 2005), and 
alkenes (Zhang et al., 2002).  
 Genetic code expansion in E. coli has largely relied on amber suppression of 
engineered tRNA:synthetase pairs. Inherently, this is a non-efficient process because 
amber suppression by tRNAs directly competes with the native release factor machinery. 
In E. coli, release factor 1 (RF1) is responsible for termination of translation in response 
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to the amber codon. Theoretically, deleting the RF1 gene all together would eliminate the 
competition with NAA amber suppression efficiency - however, deletion of RF1 is lethal 
in E. coli (Rydén and Isaksson, 1984). Recently researchers have developed viable RF1 
knockout strains that improve amber suppression efficiency (Johnson et al., 2011; Mukai 
et al., 2010). These strains rely on the presence of amber suppressors to achieve viability, 
and required genomic editing to proteins with amber stop codons that suffer fitness 
defects with the C-terminal addition of amino acids. To bypass these issues all together, a 
monumental effort by Isaacs and Church has led to an E. coli strain that contains no 
amber stop codons (Isaacs et al., 2011; Lajoie et al., 2013). This ‘amberless’ organism 
greatly improves the NAA incorporation machinery and results in increased expression of 
proteins with novel amino acid sidechains. 
 In addition to modification of the tRNA:synthetase pair and recoding the 
organism, ribosomes themselves have been engineered. For example, ribosomes have 
been mutated in the peptidyl transferase center that allowed the incorporation of D-amino 
acids and therefore the synthesis of backbone modified proteins (Dedkova et al., 2003). 
Chin and colleagues have developed orthogonal ribosomes in E. coli by mutating the 
anti-shine dalgarno sequence on the 16S subunit, which led to enhancement of amber 
suppression efficiency (Wang et al., 2007). The orthogonal ribosome opens the 
opportunity for mutating the ribosome without catastrophic cellular consequences, as 
‘normal’ messages would be read by the wild-type ribosome. However, modifications to 
the 23S would not be as accepted because orthogonality cannot be achieved in the same 
fashion. To overcome this, an incredible engineering feat was achieved by the fusion of 
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the 16S and 23S subunits of the bacterial ribosome (Orelle et al., 2015). This enables the 
possibility of mutation of both subunits without severe fitness effects in vivo. 
 While still in its infancy, the evolutionary and biotechnology consequences of 
expanded genetic codes are beginning to take shape. The evolutionary potential of 
expanded genetic codes was tested using bacteriophage T7 as a model organism 
(Hammerling et al., 2014). This was chosen because the host, E. coli, could be freshly 
infected every several generations of phage – preventing the mutation of the NAA 
machinery. Serial passages increased fitness of the population and in some phage 
lineages, amber codons became fixed in the population. For instance, a holin lysis protein 
contained an amber codon (and therefore the NAA, 3-iodotyrosine) which was 
demonstrated to increase the fitness of the phage in an amino acid specific manner. This 
simple experiment points towards NAAs being valuable biotechnology tools into the 
future. One such use would be to use NAAs as a biocontainment strategy, relying on 
NAAs for survival (Mandell et al., 2015; Tack et al., 2016; Thyer et al., 2015). This was 
possible by making the function of essential genes dependent on the NAA, either in the 
form of metabolic genes or resistance markers. These techniques have largely relied on 
exploitation of the folding dynamics of proteins, but it is likely that NAAs will be shown 
to be advantageous in the active site of enzymes as well.  
EMULSIONS AS A TOOL FOR MOLECULAR EVOLUTION 
 A link between genotype and phenotype is a requirement for the evolution of 
living systems. This is seen throughout nature, as cells go through great lengths to keep 
out foreign genetic information. Spontaneous genotypic mutations that correspond to 
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positive fitness phenotypes need to reproduce and outcompete mutations that are less 
beneficial. For instance, a continuous aqueous phase of mixed phenotypes and genotypes 
will often result in evolutionary instability as tested by in vitro evolutionary systems 
(Breaker and Joyce, 1994; Ichihashi et al., 2013; Mills et al., 1967). Instability is a result 
of parasitic genotypes that arise by positive phenotypes incorrectly recognizing non-
cognate genetic templates diminishing enrichment of positive genotypes. For all intents 
and purposes this linkage is presumably a fundamental feature of life itself (Deamer and 
Dworkin, 2005; Meyer et al., 2012; Szathmáry and Demeter, 1987). 
 In most living systems the genotype-phenotype linkage is achieved by 
containment of genetic information into a cell. A fatty acid membrane envelops the 
genome of a given organism preventing cross metabolism with other cells that may be 
around. At the origin of life, how was such a linkage maintained, especially without the 
complex machinery involved in membrane biosynthesis? Several alternative strategies 
have been postulated, such as nucleic acid targeting sequences ('guides') to coordinate 
proximity of the correct genotype-phenotype pairs (Lincoln and Joyce, 2009; Vaidya et 
al., 2012), or the eutectic phase of ice crystals preventing cross reactivity of genotypes 
(Attwater et al., 2010). 
 Compartmentalization has been an invaluable tool for the in vitro evolution of 
biomolecules. In 1998, Tawfik and Griffiths published a seminal paper describing the 
creation of water-in-oil emulsion compartments to perform in vitro molecular evolution 
(Tawfik and Griffiths, 1998). By combining particular recipes of oil, surfactant 
(amphiphilic molecules), and an aqueous solution using a mechanical force, miniature 
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compartments ranging from 2-4 microns could be created. In a single milliliter there are 
up to 1010 emulsion droplets that are approximately four femtolitres in volume (roughly 
the volume contained in a bacterial cell). Each of these emulsion bubbles act as a distinct 
molecular bioreactor, enabling a massively parallel experiment. This is achieved because 
compartments do not cross react - large molecules such as nucleic acids and proteins 
cannot escape a given compartment. This sets up the necessary requirement for molecular 
evolution - the genotype and phenotype linkage.  
 Initially, molecular evolution experiments were focused around the modification 
of the template molecule itself. DNA templates are emulsified with an in vitro 
transcription / translation mix, such that a single template will enter a single emulsion 
bubble. The DNA template is designed with a promoter sequence (typically the T7 RNA 
polymerase promoter), which will transcribe the encoded gene. Subsequently, translation 
of the encoded gene will occur from the mRNA transcript using the translation apparatus 
in the mix. Usually, this machinery comes from cell lysates that are depleted of 
endogenous mRNA, but can also be purified reconstituted systems such as the PURE 
system (Shimizu et al., 2001).  
 Using the basic principles of emulsions, Tawfik and coworkers over the next 
several years put out successive proof of principle variations of this technique. In the 
initial paper, the in vitro selection was based around the methylation of the DNA 
encoding HaeIII methyltransferase which protected templates from digestion during 
HaeIII endonuclease treatment (Tawfik and Griffiths, 1998). In a subsequent experiment, 
the amino acids involved in DNA template recognition were investigated by 
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randomization of residues followed by reselection of the native recognition sequence 
(Lee et al., 2002). This demonstrated the utility of emulsion based directed evolution for 
probing enzyme function. Following this, the DNA recognition of the HaeIII 
methyltransferase was modified – validating that the technique could alter enzymatic 
function (Cohen et al., 2004). Amino acid residues in the HaeIII methyltransferase were 
randomized and tasked with recognition and methylation of an altered DNA site (GGCC 
to AGCC) to protect from subsequent digestion from the NheI endonuclease. The 
resulting mutants of HaeIII methylated this altered site with several hundred-fold 
improvement of catalytic efficiency, but the mutant was promiscuous for several DNA 
sites. Given results from other experiments, the specificity could likely be improved by 
negative selection steps.  
 Additional variations of the emulsion scheme were developed. One of the main 
disadvantages of the emulsification is that once emulsified manipulation of the genes of 
proteins inside is difficult. For instance, the function of a particular enzyme (buffer 
conditions, substrates, temperature) may not be compatible with the in vitro transcription 
/ translation system used to produce the proteins in the first place. Additionally, the 
previous examples have been limited to enzymatic modification of the template DNA. 
Many gene functions of interest however do not modify DNA. In order to bypass these 
issues, several additional techniques were layered. The use of fluorescence based cell 
sorting (FACS) was coupled with the emulsion based system by creating a double 
emulsion (Bernath et al., 2004). Because FACS instruments are not designed to 
microfluidically handle oil phase, oil based droplets were put through a ‘secondary 
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emulsion’ which made the main constituent an aqueous phase (a so called water in oil in 
water emulsion). Accumulation of fluorescent based products inside individual emulsion 
bubbles enables the FACS instrument to sort individual compartments. A second scheme 
was also invented to bypass these limitations, wherein streptavidin coated beads were 
included in the emulsion reaction. These beads serve to capture products of the emulsion 
reaction during the in vitro transcription and translation phase. For instance, DNA can be 
captured by the addition of a biotin labeled tag and proteins can be captured with 
antibodies affixed to the bead’s surface (Sepp et al., 2002). Upon breaking the emulsion, 
genes and proteins are linked together by physical attachment to the bead and can be 
probed for function. For example, enzymatic labeling of a fluorescent dye to the bead 
enables FACS based enrichment of active genes. These techniques were used for the 
evolution of a phosphotriesterase for faster catalytic turnover from a large library of 
variants (>107) (Griffiths and Tawfik, 2003). 
 In addition to the selection of protein enzymes, the emulsion based techniques 
have been used for selection of catalytic RNAs. The Bartel ligase was evolved using a 
bead based affixing technique followed by subsequent FACS (Levy et al., 2005), 
selecting RNA ligases that were more efficient at multiple catalytic turnover. Similarly, a 
Diels-Alderase ribozyme was selected from a random pool of ribonucleotides by 
emulsification and catalytic attachment of a biotin to the template by formation of the 
cyclohexene ring (Agresti et al., 2005). And perhaps most impressively, ribozyme 
polymerases have been evolved using emulsion based methods (Wochner et al., 2011; 
Zaher and Unrau, 2007). These methods have greatly improved the polymerase ribozyme 
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originally selected by David Bartel’s group (Johnston et al., 2001), creating polymerases 
capable of extending a primer hundreds of nucleotides (Attwater et al., 2013; Wochner et 
al., 2011).  
 Emulsions also have the capacity for evolving much more complex phenotypes. 
Several evolutionary systems have been evolved in emulsion compartments that almost 
begin to resemble phage like lifecycles. For instance, synthetic operons have been 
evolved in emulsions that require the cooperativity of multiple gene functions. In one 
such system, the combined function of streptavidin and the biotin ligase, BirA, must 
function together to survive (Levy and Ellington, 2008; Lu and Ellington, 2014). Another 
example is the simple self-replicating T7 system, termed the ‘autogene,’ which requires a 
feedback based system for self amplification. Emulsification of the autogene system 
allowed the evolution of T7 RNAP over multiple cycles of self-replication (Davidson et 
al., 2012). In the most life-like example, the Q-beta replicase was evolved in an E. coli 
transcription / translation system (Ichihashi et al., 2013). This intriguing study found that 
emulsification was essential for evolving the Q-beta replicase by preventing 
accumulation of molecular parasites. Over the course of evolution, the system adapted to 
mitigate the molecular parasites that would arise throughout genome replication. These 
examples show that emulsion-based compartmentalized systems can evolve and have 
protocellular-like behavior.   
 Dividing a single reaction into billions of small reaction vessels is an extremely 
useful technique beyond molecular evolution technologies. The ability to encapsulate a 
single DNA template and perform amplification reactions has proven valuable for next-
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generation sequencing technologies (Margulies et al., 2005; Shendure, 2005). Single 
DNA molecules can be replicated giving rise to monoclonal amplification, which can 
create a bead homogenously labeled with DNA from a complex pool of DNAs. The same 
principle can be used for amplifying RNAs by the addition of a reverse transcriptase to 
clonally amplify single RNA molecules (Nakano et al., 2005). Similar techniques can be 
used to identify rare single nucleotide polymorphisms that may be disease markers 
(Dressman et al., 2003). Emulsion PCR based amplification of rare alleles offers a 
number of advantages over single reaction amplification, as rare sequences will not be 
lost due to being out competed in PCR replication. Additionally, pairs of genes can be 
linked inside emulsion compartments which has proven extremely valuable for the 
pairing of antibody variable regions in the heavy and light chains (DeKosky et al., 2013, 
2015).  
POLYMERASE EVOLUTION USING COMPARTMENTALIZED SELF REPLICATION 
 A variation of the methods developed by Griffiths and Tawfik was conceived by 
Philipp Holliger for the evolution of thermostable DNA polymerases (Ghadessy et al., 
2001). This selection scheme relies on the self-replication of thermostable DNA 
polymerases inside of an emulsion reaction. Compartmentalization of E. coli cells 
bearing the polymerase variants (and corresponding templates) with buffers, dNTPs, and 
primers provides the means for self replication to occur upon thermal cycling.  
 This compartmentalized self replication (CSR) scheme has several features that 
are distinct from the aforementioned methods. First, instead of using in vitro transcription 
and translation mixes, the protein production is achieved inside of E. coli cells. Libraries 
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of polymerase variants are constructed and transformed into cells, which also serve to 
maintain a genotype-phenotype linkage. Expression of polymerases inside of cells has 
several advantages over the use of lysates. Multiple copies of the template are available 
during the subsequent reaction (for multicopy plasmids) and protein expression inside of 
E. coli is generally more robust than those achieved in lysates. Second, the emulsion 
itself must support thermal cycling and sustained high temperatures without collapse of 
individual compartments. Third, the CSR directly amplifies the templates inside of the 
emulsion instead of relying on the post-emulsion selection of templates through 
modification, sorting, or affinity binding. The direct amplification enables modulation of 
selection parameters by altering the reaction conditions present to the polymerase. These 
customizable parameters enable the selection of polymerases with an assortment of 
properties (Fig. I.2).  
 Perhaps the simplest CSR evolution scheme is the addition of molecules that 
would normally inhibit PCR polymerization. In the original manuscript, it was shown that 
variants of Taq polymerase could be evolved that have increased resistance to heparin 
(which binds to the polymerase’s active site inhibiting primer extension) (Ghadessy et al., 
2001). In a subsequent study, gene shuffling of Taq with orthologous sequences followed 
by CSR containing various environmental inhibitors led to the discovery of polymerases 
that are inhibitor resistant (Baar et al., 2011). These polymerases are of diagnostic and 
forensic value, as oftentimes environmental or biological samples contain inhibitors to 
PCR. 
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 The modification of DNA primer sequences in CSR can also lead to the evolution 
of polymerases with interesting properties. For instance, designing primer sequences that 
purposefully contain mismatches at their 3’ end can evolve polymerase variants with 
unique properties. Polymerases evolved under these conditions are less fussy about the 3’ 
complementarity and can bypass common template blocking lesions such as abasic sites 
(Ghadessy et al., 2004). These polymerases were also shown to behave more favorably 
when incorporating unnatural base analogs such as 7-deaza-dGTP, as incorporation of 
these bases might prevent further extension and inhibit PCR. The primer modification 
technique was further employed for more drastic mismatches in the primer-template 
complex in a subsequent selection (d’Abbadie et al., 2007). The resulting polymerases 
were used for ancient DNA samples that contain damaged genetic information which 
would otherwise prevent effective PCR amplification for sequencing reactions.  
 During self-replication in the emulsion compartment, swapping the native dNTPs 
for nucleotide analogs puts evolutionary pressure during CSR for the incorporation of 
these unnatural bases. In order to achieve effective self-replication polymerases must 
expand their substrate specificity to accommodate the substrates in the given reaction. 
For instance, substitution of dATP for ATP in the CSR reaction forces polymerase 
variants to incorporate ATP in order to efficiently self-replicate. Using this approach, 
several rounds of evolution produced polymerases that were capable of being a DNA, 
RNA, and reverse transcriptase simultaneously (Ong et al., 2006). This approach has 
been used for other base analogs, such as, fluorescently labeled dNTPs and hydrophobic 
base analogs (Loakes et al., 2009; Ramsay et al., 2010). However, the incorporation of 
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such bases is a large evolutionary hurdle and required the self-replication of just the DNA 
comprising the active site. In addition, reverse transcriptases which could convert this 
information back into DNA would be needed. 
 To bypass these issues a new selection methodology was created that would 
enable the evolution of polymerases with wildly altered sugar backbones. Instead of 
relying on the entire self-replication of polymerase sequences, a strategy was developed 
that would instead enable the capturing of the plasmids that encoded the polymerase 
variants (Pinheiro et al., 2012). Polymerase libraries were constructed and selected to 
polymerize a number of modified sugar dNTPs including: CeNAs, LNAs, ANAs, FANA, 
and TNAs. These polymerases could support in vitro evolution of functional nucleic 
acids including aptamers and ribozymes that are entirely composed of synthetic DNA 




Figure I.1 : Alterations to the central dogma 
Although Crick's Central Dogma is highly conserved (performing the chemistries of life's 
functions), it is surprisingly malleable. Natural substrate flexibility or engineering efforts 
have left the central dogma with many altered functionalities. 
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Figure I.2 : Evolving novel function using Compartmentalized Self Replication 
Compartmentalized Self Replication (CSR) is widely adaptable for evolving polymerase 
function. Slight modifications to the selection parameters have enabled the evolution of 
polymerases with many novel functionalities. For example, CSR has evolved 





Chapter 1:  Directed Evolution of Genetic Parts and Circuits by 
Compartmentalized Partnered Replication 
 
 Most existing in vivo and in vitro directed evolution methods suffer from 
inadvertent selective pressures (i.e. altering organism fitness), resulting in the evolution 
of products with unintended or suboptimal function.  To overcome these barriers, here we 
present compartmentalized partnered replication (CPR). In this approach, synthetic 
circuits are linked to the production of Taq DNA polymerase so that evolved circuits that 
most efficiently drive Taq DNA polymerase production are enriched by exponential 
amplification during a subsequent emulsion PCR step. We apply CPR to evolve a T7 
RNA polymerase variant that recognizes an orthogonal promoter and to reengineer the 
tryptophanyl tRNA-synthetase:suppressor tRNA pair from Saccharomyces cerevisiae 
(Hughes and Ellington, 2010) to efficiently and site-specifically incorporate an unnatural 
amino acid into proteins. In both cases, the CPR-evolved parts were more orthogonal 
and/or more active than variants evolved using other methods. CPR should be useful for 
evolving any genetic part or circuit that can be linked to Taq DNA polymerase 
expression. 
INTRODUCTION 
 With the emergence of sophisticated DNA synthesis and cloning techniques, the 
creation of in vivo-based synthetic circuitry has become commonplace (Gibson, 2011; 
Hughes et al., 2011). However, in contrast to the relative ease with which one can design 
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electronic circuits exhibiting predictable and precise behavior, it is not yet possible to 
reliably design biological pathways of equivalent complexity (Temme et al., 2012a).  
Most methods for refining synthetic circuits so that they behave in a more predictable and 
reliable manner rely on the bioengineering principles of screening and selection; 
however, this process has proven challenging in part because of the inherent linkage of 
the host organism’s fitness and the circuit’s function (Tan et al., 2009). Evolution and 
engineering techniques including phage-assisted continuous evolution (PACE) (Esvelt et 
al., 2011) and multiplex automated genomic engineering (MAGE) (Wang et al., 2009) 
were developed to better facilitate engineering of synthetic circuits, but each technique 
has limitations.  PACE relies on a viral replication cycle, thus limiting control over the 
evolutionary process; while MAGE has relied on manual screening of the libraries 
generated and is therefore time consuming and laborious.  Here we present 
compartmentalized partnered replication (CPR), an engineering platform capable of 
efficiently improving synthetic gene circuitry by utilizing advantages of both in vivo and 
in vitro approaches.  
In a previously described related method called compartmentalized self-
replication, DNA polymerases produced in cells facilitate the compartmentalized in vitro 
amplification of their own genes (Ghadessy et al., 2001),(Ghadessy and Holliger, 2007).  
While this technique has proven to be effective for the evolution of novel DNA 
polymerases, the method is of limited utility for the evolution of other genes or genetic 
circuits. CPR addresses this limitation by allowing coupling of Taq DNA polymerase 
production to a variety of other gene functions; these gene functions form the synthetic 
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circuit of interest.  As such, synthetic circuits that most efficiently drive Taq DNA 
polymerase production in cells in the in vivo step will be preferentially amplified during 
the subsequent compartmentalized in vitro PCR step (Fig. 1.1).  More specifically, a 
library of genetic circuits or parts designed to drive expression of Taq DNA polymerase 
is transformed into E. coli. Host cells are then separated into emulsion compartments that 
contain primers specific for the genetic circuit or part.  Upon thermal cycling, cell lysis 
occurs and the compartment-to-compartment variations in abundance of Taq DNA 
polymerase result in preferential amplification of genes in compartments containing the 
most Taq DNA polymerase; these compartments correspond to the cells transformed with 
the most efficient genetic circuits or parts.  CPR is a modular platform that should in 
theory be capable of evolving almost any genetic part or circuit that can influence Taq 
DNA polymerase production or activity.  Here, to demonstrate the capacity of CPR to 
effectively evolve genetic circuitry and to facilitate comparison to other molecular 
engineering methods, CPR was wired to evolve circuitry for two important and ongoing 
synthetic biology efforts: the generation of orthogonal transcription machinery and 
expanding the genetic code. 
RESULTS 
Evolution of T7 RNA Polymerase Promoter Recognition 
 We first constructed a genetic circuit in which transcription of Taq DNA 
polymerase relies on T7 RNA polymerase (T7 RNAP) binding to and activating its 
promoter (Figure 1b). As a proof of principle, we initially coupled the production of Taq 
DNA polymerase to a wild-type (WT) T7 RNA polymerase promoter (PT7), and 
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generated a library of T7 RNA polymerase variants in which the six amino acids of the 
T7 RNAP specificity loop (Cheetham et al., 1999) (R746, L747, N748, R756, L757, 
Q758; RLN…RLQ) were fully randomized. The library was transformed into E. coli, and 
the cells were emulsified in the presence of primers specific for the T7 RNAP gene. 
Presumably, cells expressing those T7 RNAP variants that most efficiently bound to and 
activated PT7 contained higher amounts of Taq DNA polymerase. Heat lysis released 
Taq DNA polymerase and T7 RNAP gene variants into individual emulsion bubbles, and 
the emulsion bubbles were subjected to thermal cycling. After four iterative rounds of 
this process, the library enriched for variants driving robust expression from the PT7 (As 
shown by GFP expression from PT7) and converged on a consensus sequence resembling 
that of wild-type T7 RNAP, although some variation remained at the non-critical 
positions L747 and L757.     
 Based on this result, we attempted to evolve more orthogonal circuitry.  
Specifically, the randomized specificity loop library was tasked with driving Taq DNA 
polymerase expression from a promoter, PCGG, which differed from PT7 at -11, -10, and 
-9 positions. After seven rounds of CPR, a single sequence “RVH…EMQ” dominated the 
population, and transcriptional activity of an evolved variant bearing this motif (CGG-
R7-8) was analyzed.  While the CGG-R7-8 T7 RNAP activated expression of GFP driven 
by the PCGG promoter, this activation was equivalent to only 2% of the activity of WT 
T7 RNAP on the WT PT7 promoter. Therefore, we reasoned that additional T7 RNAP 
mutations, not present in the initial library, were needed to compensate for the changes to 
the promoter sequence.   
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 To further improve the activity of the CGG-R7-8 polymerase on the PCGG 
promoter, we performed an addition five rounds of selection by CPR, with a larger (ca. 
500bp) region of the CGG-R7-8 polymerase immediately flanking the specificity loop 
subjected to error prone PCR before the first and fourth round. We transformed the 
Round 12 population into E. coli expressing a PCGG-driven GFP reporter, and 
characterized the 8 T7 RNAP variants that drove the highest GFP expression. The most 
active T7 RNA polymerase variant from this population, which we termed CGG-R12-KI, 
displayed 20% the activity of the WT T7 RNAP:promoter pair . 
 Additional mutations beyond those seen in CGG-R12-KI were also frequently 
observed in variants in the round 12 population.  We inserted combinations of three of 
these additional highly represented mutations to CGG-R12-KI; this further improved its 
in vivo activity to roughly 40-60% of the WT T7 RNAP:promoter pair.  The five most 
active variants were mixed in equal ratios and selected by CPR for an additional 4 rounds 
(with error prone PCR before the first, third, and fourth round).  This resulting round 16 
population closely resembled the mutant CGG-R12-KIRV which robustly drove the 
expression of GFP from the PCGG promoter but demonstrated only minimal activity on 
the PT7 promoter (~1% cross-reactivity) (Fig. 1.2).  In turn, the WT T7 RNAP did not 
markedly drive expression of the PCGG-GFP reporter in vivo.   When expressed, 
purified, and assayed in vitro, CGG-R12-KIRV and WT T7 RNAP also demonstrated 
less than 0.1% promoter cross-creativity.   
 Although T7 RNAP variants bearing altered promoter specificity have been 
evolved and engineered over two decades by various means (Chelliserrykattil et al., 2001; 
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Esvelt et al., 2011; Raskin et al., 1993; Temme et al., 2012b), the CPR-evolved CGG-
R12-KIRV is the most orthogonal and among the most active T7 RNAP:promoter pair 
when compared with previously described engineered and evolved T7 RNAP variants 
(Fig. 1.2). 
Evolution of Aminoacyl tRNA Synthetase Amino Acid Specificity 
 Next, CPR was applied to evolve an orthogonal aminoacyl tRNA 
synthetase:tRNA pair facilitating site-directed incorporation of an unnatural amino acid, 
5-hydroxy-L-tryptophan (5HTP).  Previously, the tryptophanyl tRNA synthetase from 
Saccharomyces cerevisiae (ScWRS) and its corresponding suppressor tRNA have been 
adapted to the orthogonal suppression of amber codons in E. coli(Hughes and Ellington, 
2010).  To redirect CPR for evolving synthetic translation machinery, we generated a Taq 
DNA polymerase variant containing amber stop codons, and attempted to evolve variants 
of both a tRNA synthetase and its cognate suppressor tRNA with altered substrate 
specificity and improved amber suppression efficiency.  
 Based on the previously described crystal structure of the yeast tryptophanyl 
tRNA synthetase, we randomized three residues adjacent to the presumed position of the 
5-hydroxy moiety in the tryptophan analogue (T107, P254, and C255) (Zhou et al., 
2010).  The library was transformed into an E. coli strain which expressed an amber 
codon-containing Taq DNA polymerase and  grown in media supplemented with 5HTP.  
After each of three rounds of CPR, the library became more enriched for tRNA 
synthetase variants capable of amber suppression.  Mock selections indicated that we 
could expect up to 100-fold enrichment per round of CPR; thus three rounds of selection 
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and amplification should have substantively narrowed the initial pool of tRNA 
synthetases.  Individual tRNA synthetase variants were picked and screened for activity 
using a modified E. coli strain with an amber codon in the β-galactosidase gene. Several 
tRNA synthetase variants effectively suppressed the amber codon, resulting in a visibly 
blue colony, only when 5HTP was present (Fig. 1.3). The most active and specific utilizer 
of 5HTP , 5OH-R3-13, had the amino acid substitutions T107C, P254T, and C255A.  
Mutational analysis of single and double mutants of 5OH-R3-13 demonstrated that 
although it does not directly contact the 5-hydroxy moiety, the T107C mutation was the 
crucial step towards specificity (Fig. 1.4).  In the wild-type tRNA synthetase binding 
pocket, T107 appears to be hydrogen-bonding with the carbonyl oxygen between residues 
P254 and C255.  Mutation of T107 may eliminate this bond and instead allow the 5-
hydroxyl moiety to hydrogen-bond with the carbonyl oxygen. Further specificity is 
gained after mutating P254C, potentially stabilizing the pocket with an additional 
hydrogen bond to T127 or perhaps allowing greater flexibility to the beta-sheet adjacent 
to the 5-hydroxyl moiety, while C255A may prevent a possible steric clash.   
 To determine if the variant 5OH-R3-13 site-specifically incorporated 5HTP, the 
enzyme was co-expressed with a modified version of dihydrofolate reductase (DHFR) 
that contained an amber codon at position 10 (V10amber) in the presence of rich 2xYT 
media supplemented with 5HTP. Purified DHFR proteins were characterized by top-
down ultraviolet photodissociation mass spectrometry (Shaw, J.B., Li, W., Holden, D.D., 
Zhang, Y., Griep-Raming, J., Fellers, R.T., Early, B.P., Thomas, P.M., Kelleher, N.L., 
Brodbelt, 2013).  The presence of a single mass shift of ~16 Da, indicative of the single 
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incorporation of 5HTP in place of tryptophan, was detected in the 5OH-R3-13 samples 
but not in the WT tRNA synthetase samples (Fig. 1.3).  Fragmentation analysis verified 
that 5HTP was in fact incorporated at position 10, corresponding to the location of the 
amber codon.  Incorporation fidelity was estimated to be approximately 85%, despite 
growth in rich media in the presence of abundant tryptophan.  When compared with the 
wild-type ScWRS enzyme the evolved 5OH-R3-13 synthetase showed 1,500-fold 
improvement incorporating 5HTP (ratio of peak density in. 
Evolution and Optimization of Orthogonal tRNAs   
 Optimization of orthogonal tRNAs (as opposed to tRNA synthetases) can also 
have a substantial impact on the efficiency of unnatural amino acid incorporation (Young 
et al., 2010).  As the S. cerevisiae tRNA is already highly efficient, it is unlikely that its 
interaction with other parts of the E. coli translation machinery, such as elongation 
factors or the ribosome, will be optimized.   Three tRNA libraries were constructed 
randomizing either the anticodon stem, acceptor stem, or loop sequences (Fig. 1.5).  Each 
library contained roughly 106 different tRNA variants, and we subjected each library to 
ten rounds of CPR.  To increase selection pressure, we progressively increased the 
number of amber codons in the open reading frame of the Taq DNA polymerase (up to 
six), as well as, reducing the expression of the orthogonal tRNA synthetase.  Moreover, 
to show that CPR could potentially be used to co-evolve entire genetic circuits (as 
opposed to a single part in a circuit), the wild-type tRNA synthetase was also allowed to 
mutate during the selection of the suppressor tRNA libraries.  After ten rounds, several 
circuits containing co-evolved tRNA synthetase and tRNA pairs were assayed via flow 
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cytometry by their ability to suppress GFP bearing 3 amber codons. Although some 
neutral and silent mutations were detected in the tRNA synthetases, as might be expected 
most of the mutations accrued within the tRNA libraries.  Seven of ten tRNA variants 
displayed more efficient amber suppression than the parental suppressor tRNA (which 
itself had previously been improved over the wild-type yeast suppressor tRNA by rational 
mutagenesis). The two best tRNA variants (40A and 49A) were roughly 3- and 4-fold 
more active than the parental tRNA (AS3.4) and in consequence likely 12-fold better than 
the wild-type tRNA (Fig. 1.3). Both suppressor tRNA variants were assayed for cross-
utilization by E. coli tRNA synthetases by determining whether they could suppress a 
single amber codon in a β-galactosidase or GFP gene, in the absence of functional 
ScWRS.  The 49A tRNA variant displayed some background charging by endogenous 
synthetases, but the 40A variant (loop mutations U16G, G43U, U58G) appeared to be 
completely orthogonal.  
 We hypothesized that the efficiency of the CPR-evolved 5HTP incorporating 
5OH-R3-13 tRNA synthetase would be improved by pairing it with the CPR-evolved 
40A suppressor tRNA.  When combined, these optimized parts drove 8.5-fold higher 
expression of GFP containing 3 amber codons in the presence of 5HTP relative to the 
parental AS3.4 tRNA (Fig. 1.3).  Similarly, when DHFR (containing one amber) was 
expressed in cells expressing both the 5OH-R3-13 synthetase and 40A suppressor tRNA, 
mass spectrometry experiments confirmed no loss of fidelity of 5HTP incorporation 
despite the improved suppression efficiency.  The efficiency with which 5HTP is 
incorporated into these proteins containing multiple amber codons is particularly 
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impressive given that other evolved synthetase:tRNA pairs have only been shown to be 
capable of suppressing one amber codon with an unnatural amino acid (Johnson et al., 
2011). 
DISCUSSION   
Advantages of CPR Compared to Other Directed Evolution Techniques 
 One advantage of compartmentalized partnered replication is its ability to select 
for gene part or circuit function in vivo without being confounded by the need to 
simultaneously select for organismal fitness.  This is because the short duration of the in 
vivo functional selection limits fitness effects that may disfavor highly active circuits.  
Another advantage is that the subsequent in vitro replication phase enables the 
exponential amplification of the most active circuits.  These attributes likely lead to better 
functioning circuits being selected over a range of functionality (Fig. 1.6), meaning that 
even genetic parts or circuits resulting in initially weak phenotypes (in other words, 
inducing only a small difference in Taq DNA polymerase expression) can be established 
in the population and that the most active variants can ultimately come to dominate.  
Finally, the discontinuous nature of the selection process offers a much-needed element 
of control that limits parasite accumulation (Breaker and Joyce, 1994; Bull and Pease, 
1995),  avoids extraneous mutations impacting the selection (Dickinson et al., 2013; 
Goldsmith and Tawfik, 2009), and enables a part to be evolved largely in the context in 
which it will be used. 
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Future Directions 
 The evolution of transcription and translation machinery suggests that CPR can 
evolve enzymes and RNAs that are highly active and specific.  By simply rewiring the in 
vivo circuit-based architecture to favor the production of Taq DNA polymerase in other 
ways, CPR can potentially be adapted to the evolution of regulatory parts such as 
transcription factors, repressors, and riboswitches, as well as larger genetic ensembles 
such as operons and biosynthetic pathways.   
MATERIALS AND METHODS  
T7 RNAP library design and selection 
 Site saturation mutagenesis was used to randomize the residues R746, L747, 
N748, R756, L757, and Q758 of the T7 RNAP promoter specificity loop. The degenerate 
oligonucleotide was synthesized in-house on an Expedite 8900 synthesizer using reagents 
and phosphoramidites purchased from Glen Research at a 40 nmol synthesis scale.  
Degeneracy was introduced into the oligonucleotides via the use of trimer 
phoshoramidites containing a mixture of 20 trimer (codon) phosphoramidites encoding 
all twenty amino acids. Primer-sets each introduced different silent mutations ("water-
marks") up and down stream of the randomized regions.  These allowed for specific 
amplification as well as identification upon sequencing.  
 The non-randomized portions of T7 RNAP were amplified from pQE-RSS.  “T7 
RSS” is a previously synthesized version of the T7 RNAP that was optimized for reduced 
secondary structure of the mRNA(Davidson et al., 2012).  All selections and initial 
characterizations were performed with this codon set to avoid contamination during the 
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selection process.  All protein purification and comparison to other mutants were 
performed with wild-type codon set in order to provide a more fair representation of said 
mutants.  In all cases, every polymerase used the same codon set for a given assay.   
 The N-terminal portion of the T7 RNAP coding sequence was amplified from 
pQE-RSS; the C terminal portion of the T7 RNAP coding sequence was amplified from 
pQE-RSS.  The three portions were then assembled by overlap PCR (N-term:library:C-
term at a 1:2:1 molar ratio).  The assembly PCR and an empty pQE vector were each 
digested with BamHI and HindIII (New England Biolabs).  Insert and vector were mixed 
at a 2.3:1 molar ratio (~2.5 μg total), incubated with 2000 U T4 DNA ligase (New 
England Biolabs), and incubated at 14oC for at least 15 hours.  All PCR steps (other than 
those in emulsion PCR) were performed using Accuprime Pfx DNA Polymerase (Life 
Technologies) per manufacturer’s instructions.  All PCR and digestion products were gel 
purified using QIAquick Gel Extraction Kit (Qiagen) and ligations were purified with SV 
Wizard PCR clean-up (Promega) prior to electroporation.        
 The wild-type Taq DNA polymerase gene was cloned into a modified pACYC-
duet (Novagen) backbone with a single T7 promoter.  Bl21 gold cells (Agilent) were 
transformed with pACYC-Taq (or its derivative with altered promoter) and grown in bulk 
overnight.  250 μl of this culture was subcultured in 20 ml 2xYT medium and grown at 
37oC for 2 hours (OD600 ~0.5).  The culture was then spun and washed with ice cold 
10% glycerol 4 times, with the fourth resuspension in 100 μl 10% glycerol.  This cell 
slurry (~200 μl total) was combined with 2-10 μl purified ligation and using 
electroporated 0.2 cm cuvettes at 2.5 kV in an E. coli pulser (Biorad).  This routinely 
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resulted in 2 x 107 CFUs (multiple replicates were pooled for early rounds in order to 
attain full coverage).   
 100 μl overnight transformation cultures were subcultured in 2 ml 2xYT medium, 
grown for 1 hour (OD600 ~0.6) and induced with 0.3 mM IPTG at 37oC for 4 hours.  
200 μl of the induction culture was centrifuged (10 min: 5,000g) to pellet the cells.  The 
supernatant was removed and cells were gently resuspended in 20 μl 10x PCR buffer 
(500 mM KCl, 100 mM Tris-HCl pH 8.3, 15 mM MgCl2) 10 μl dNTP mix (4 mM each), 
4 μl CPR.F primer (20 uM), 4 μl CPR.R primer (20 μM), and 162 μl water.  
 Emulsification was performed by slowly adding resuspended cells to 600 μl of 
spinning oil mix (438 μl Tegosoft DEC (Evonik), 42 μl AbilWE09 (Evonik), and 120 μl 
Mineral oil (Sigma)). The oil mixture was constantly spun in a tube (Sarstedt 13 ml 95 
mm x 16.8 mm) on ice using a stirbar (Spinplus 9.5 mm x 9.5 mm Teflon, Bel-Art) on a 
magnetic plate (Corning) at the maximum setting (1150 rpm). The cell mixture was 
slowly added over a 1 minute interval and spun for an additional 4 minutes. The 
emulsified cells were thermal cycled (95oC:3min, 20 cycles [95oC:30s, 55oC:30s, 
72oC:2min/kb], 72oC:5 min) such that cells containing the most active enzymes will also 
contain the most Taq DNA polymerase and will preferentially PCR amplify. The 
emulsion was broken in two steps. Firstly, it was spun down by centrifugation (5 min: 
10,000g) and the oil (upper) phase was removed. Secondly, 300 μl of H2O and 500 μl 
chloroform was added and the mixture was vortexed vigorously. The mixture was 
transferred to a heavy-gel phase-lock tube (5 Prime) and upon centrifugation (2min: 
16,000g) the aqueous (upper) phase was collected along with any nucleic acids present.  
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To purify PCR amplified DNA from plasmid DNA we used a 5' biotinylated primer such 
that products amplified from Taq DNA polymerase can be purified away from plasmid 
DNA using streptavidin coated beads (MyOne Streptavidin C1 Dynabeads, Invitrogen). 
Purified DNA was used as a template for re-amplification using primers specific to the 
watermark introduced. This PCR product was used in an assembly PCR, followed by 
digestion and ligation as above.In the later rounds of the PCGG selection (after isolation 
of CGG-R7-8), a larger region of the polymerase coding sequence was recovered (and 
thus allowed to evolve).    
 CGG-R7-8 was subject to error-prone PCR and used as the input for CGG-R8.  
CGG-R12-KIV, CGG-R12-KIR, CGG-R12-KIRV, CGG-R12-KIGR, and CGG-R12-
KIGRV were combined in equal amounts, subject to error-prone PCR and used as the 
input for CGG-R13.  The recovered product of CGG-R10, CGG-14, and CGG-R15 were 
subject to error-prone PCR as described.  Briefly the reaction mixture was composed of 
50 mM KCl, 10 mM Tris-HCl pH 8.3, 2.5 mM MgCl2, 5 ug/ml BSA, 0.35 mM dATP, 
0.4 mM dCTP, 0.2 mM dGTP, 1.35 mM dTTP, 0.5 mM MnCl2, 0.5 μM each primer, 2 
ng/μl template, and 0.8 U/μl Taq DNAP (New England Biolabs) and was thermal cycled 
(95oC:4 min, 25 cycles [95oC:30s, 55oC:30s, 72oC:2m],72oC:5 min).   This achieved the 
expected 1 mutation per 500 bp. Individual variants from PT7-R4, CGG-R7, CGG-R12, 
CGG-R16 were sequenced and analyzed using Geneious software (Biomatters ltd). 
In vivo RNAP activity assays 
 A FACS optimized variant of GFP, GFP mut2(Cormack et al., 1996), was cloned 
in place of the Taq DNAP open reading frame in pACYC-Taq.  For measures of in vivo 
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activity of T7 RNAP, variants (plasmid) or pools (ligation) were electroporated into 
BL21 gold cells containing pACYC-GFPmut2 (or its derivative with altered promoter).  
Transformations were grown at 37oC overnight.  100 μl of the culture was grown in 2 ml 
2xYT medium at 37oC for 1 hour (OD600 ~0.6) and induced at 0.05 mM IPTG for 4 
hours.  This concentration of IPTG was chosen in order to limit metabolic overload on 
the host and prevent saturation of signal.  After induction, cells were measured for 
OD600 on a Synergy-HT plate reader (Bio-Tek) and GFP fluorescence (Excitation/ 
Emission 481/507) on a Safire monochromator (Tecan).   
 Images of T7 RNA polymerase-driven GFP expression shown in Figures 2a and 
S1 were generated by spinning down 10 ml of induced culture, decanting the supernatant, 
and resuspending cells in 500 μl PBS.  The resuspended cells were excited with a UV 
transilluminator and imaged by Canon DSLR 500D digital camera. 
In vivo RNAP cross-reactivity assays 
 A promiscuous mutant of the phenylalanine aminoacyl-tRNA synthetase, PheS 
A294G(Kast and Hennecke, 1991; Thyer et al., 2013), was  cloned in place of the Taq 
DNAP open reading frame in pACYC-Taq.  T7 RNAP mutant plasmids were 
electroporated into BL21-gold cells containing pACYC-PheS with PheS A294G driven 
by the wild-type T7 promoter.  Transformations were grown at 37oC overnight.  100 μl 
of the culture was grown in 2 ml 2xYT medium at 37oC for 1 hour (OD600 ~0.6) and 
induced at 0.05 mM IPTG for 4 hours.  Cells were diluted with media (containing the 
same antibiotics and IPTG as the growth media) to OD600s of 0.1, 0.01, and 0.001.  5 μl 
of each dilution was plated on 0 mM, 5 mM, 10 mM, 15 mM, or 20 mM 4-chloro-DL-
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phenylalanine (Cl-Phe; Sigma).  The plating media also contained 0.4% glycerol, 0.5% 
yeast extract, 1% NaCl, 1.5% agar, 50 μg/ ml kanamycin, 24 μg/ ml chloramphenicol, 
and 0.05 mM IPTG.  Plates were grown at 37oC for 20 hours and imaged with ambient 
white light on a FluorChem Q (Protein Simple).  Mutant cross-reactivity may be judged 
be the dose dependent cytotoxicity of Cl-Phe, which is only lethal (at the concentrations 
used) when PheS A294G is expressed. 
In vitro transcription assays 
 For in vitro transcription assays, T7 RNAP variants were purified by standard Ni-
NTA 6xHis (N-terminal) methods.  The plasmid pQE-T7RSS (or a derivative thereof for 
T7 RNAP mutant) was transformed in BL21-gold (Agilent). Cells were grown in 2xYT 
media at 37oC until reaching OD600 ~0.7-0.8 at which point 1 mM IPTG was added. 
Cells were grown four hours at 37oC. Following induction, cells were harvested by 
centrifugation and resuspended in binding buffer (50 mM Tris-Hcl, pH8.0, 0.5 M NaCl, 5 
mM imidazole). Resuspended cells were lysed via sonication on ice using 40% probe 
amplitude for 2 minutes (1s ON, 1s OFF). Cell debris was pelleted by centrifugation 
(30min: 20,000g). His-tagged T7 RNAP was purified by immobilized metal affinity 
chromatography (IMAC). The lysate was run over 1 ml (bead volume) Ni-NTA gravity 
column pre-equilibrated with binding buffer. The column was washed with 10x column 
volumes of wash buffer (50 mM Tris-Hcl, pH 8.0, 0.5 M NaCl, 20 mM imidazole). T7 
RNAP was eluted off the column by the addition of 4x column volumes of elution buffer 
(50 mM Tris-Hcl, pH 8.0, 0.5 M NaCl, 250 mM imidazole).  Dialysis was performed in 
final storage buffer (50 mM Tris-Hcl, pH 8.0, 100 mM NaCl, 1 mM DDT, 1 mM EDTA).  
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Dialates were adjusted to 1 mg/ml and added to an equal volume of glycerol (final 
concentration 0.5 mg/ml). 
 Transcription reactions contained 40 mM Tris-HCl pH 7.0, 30 mM MgCl2, 6 mM 
spermadine, 6 mM each NTP, 10 mM DTT, 0.5 μM T7 RNAP, 0.5 μM DNA template, 
and 0.17 mg/ml DFHBI(Paige et al., 2011) in DMSO.  Reactions were incubated for up 
to 2 hours at 37oC with spinach fluorescence (Excitation/ Emission 469/501) reading 
taken every minute in a Safire monochromator (Tecan).  Spinach templates were made by 
thermal cycling 2 μM AJM.19 with  2 μM AJM.20 (for PT7-spinach) or 2 μM AJM.21 
(for PCGG-spinach) with Accuprime Pfx in its standard buffer (94°C:2 min, 12 cycles 
[94°C:15 s, 50°C:30 s, 68°C:30 s], 68°C:1 min).  Templates were purified by QIAquick 
Gel Extraction Kit (Qiagen). 
Aminoacyl tRNA synthetase CPR for site specific 5-hydroxy-L-tryptophan 
incorporation 
The binding pocket of the Saccharomyces cerevisiae tryptophanyl tRNA-Synthetase 
(ScWRS) was mutagenized by site-saturation mutagenesis at residues T107, P254, and 
C255 using NNS randomized oligonucleotides.  These residues were chosen due to their 
proximity to the 5 position of tryptophan(Zhou et al., 2010) in the binding pocket of the 
synthetase.  Libraries were prepared by overlap PCR using PFU Ultra II fusion HS 
(Agilent) and cloned into pRST.2TAA, a modified version of pRST.11BAS3.4(Hughes 
and Ellington, 2010) containing two ochre (TAA) stop codons, using HindIII and XhoI 
restriction endonucleases.  The resulting library was transformed into E. coli BL21(DE3) 
(Invitrogen) harboring the plasmid pACYC.Taq.1Amb (W167Amber) which contains an 
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amber codon in the open reading frame of Taq DNA polymerase.  The efficiency of 
transformation was >106 for each round of selection indicating several fold coverage of 
the library.  Transformed cells were grown in 2xYT media (Sigma) overnight at 37oC in 
carbenicillin (Cellgro) and chloramphenicol (Sigma).  The following morning 10 μl of 
cells were seeded into 1 ml of fresh 2xYT media with appropriate antibiotics and 1 mM 
5-L-Hydroxytryptophan (5HTP) (Sigma) and grown at 37oC for 2 hours.  The expression 
of the library of mutant synthetases and the Taq DNA polymerase was initiated by the 
addition of 1 mM IPTG.  Cells were induced at 30°C for 7 hours.  Cells were harvested 
(200 μl) by centrifugation (8 min: 3,000g) and removal of the supernatant. Cells were 
resuspended in 168 μl CPR buffer (45 mM KCL, 9 mM Tris-HCl (pH8.3), 1.4 mM 
MgCl2, 0.5 nM each CPR primer (JE.33 and JE.35), and 250 μM  each dNTP).  
 Emulsification was performed by slowly adding resuspended cells to 600 μl of 
spinning oil mix (438 μl Tegosoft DEC (Evonik), 42 μl AbilWE09 (Evonik), and 120 μl 
Mineral oil (Sigma)).  The oil mixture was constantly spun in a tube (Sarstedt 13 ml 95 
mm x 16.8 mm) on ice using a stirbar (Spinplus 9.5 mm x 9.5 mm Teflon, Bel-Art) on a 
magnetic plate (Corning) at the maximum setting (1150 rpm).  The cell mixture was 
slowly added over a 1 minute interval and spun for an additional 4 minutes.  The 
emulsified cells were thermal cycled (95oC:3min, 20 cycles [95oC:30s, 55oC:30s, 
72oC:2min/kb], 72°C:5 min) to selectively amplify functional variants. The emulsion was 
broken in two steps.  Firstly, it was spun down by centrifugation (5 min: 10,000g) and the 
oil (upper) phase was removed. Secondly, 300 μl of H2O and 500 μl chloroform was 
added and the mixture was vortexed vigorously.  The mixture was transferred to a heavy-
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gel phase-lock tube (5 Prime) and upon centrifugation (2 min: 16,000g) the aqueous 
(upper) phase was collected.  To purify CPR amplified DNA we used a 5' biotinylated 
primers, thus, products amplified by Taq DNA polymerase can be purified away from 
plasmid DNA using streptavidin coated beads (MyOne Streptavidin C1 Dynabeads, 
Invitrogen).  Purified DNA was used as a template for re-amplification using nested 
primers.  Reamplification products were cloned into the pRST.2TAA; completing one 
round of CPR selection.  Three rounds of selection were carried out using the same 
reaction conditions.  The pool activity was assayed using a β-galactosidase colony spot 
assay (Figure 3a).  Blue colonies were counted for each of the rounds and divided by the 
total, indicating that each round of selection enriched for active synthetases.  Synthetase 
variants were assayed for 5HTP specificity by patch plating colonies onto plates with or 
without the unnatural amino acid 5HTP (1 mM).  Colonies that turned blue only in the 
presence of 5HTP were putative candidates for selective incorporation.  As expected, 
some active variants were pulled from the initial Round 0 pool due to the small library 
size.  Variant 5OH-R3-13 was chosen for further analysis as it displayed the most 
pronounced β-galactosidase activity. 
tRNA CPR for improved amber suppression 
 CPR was used to select for enhanced amber suppression by randomizing key 
regions of the tRNA.  Libraries were generated using the orthogonal tRNAAS3.4 as a 
starting point and residues in the anticodon stem (AS), acceptor stem (AX), and the loop 
sequences were randomized.  CPR selections were carried out essentially as described for 
the 5HTP selection, except the stringency of selection was modulated to increase 
 48 
selective advantage for the best suppressor tRNAs.  To increase selective pressure on the 
tRNA, we modulated the: time of induction, temperature of induction, IPTG 
concentration, and most importantly the number of amber codons in the Taq DNA 
polymerase open reading frame.  The recovery strategy also changed from streptavidin 
based capture to using CPR primers with unique sequences on the 5' end.  During 
reamplification primers will anneal to the unique sequence preventing amplification of 
the contaminating plasmid DNA.  Additional diversity was introduced by error-prone 
PCR after Rounds 4, 5, and 9.  tRNA libraries were pooled after Round 3.  Amber codons 
were introduced into the Taq DNA polymerase gene at positions W167, W169, W179, 
W211, W243, and W318.  In pACYC-Taq, constructs with more than one amber codon 
were introduced additively from N to C terminus.  After ten rounds of selection, tRNAs 
were screened by flow cytometry for the ability to suppress three amber codons in 
GFPmut2 (Figure 3c, S16). The most active tRNA variants, 40A and 49A, were further 
examined to determine if they work promiscuously with other synthetases; this was done 
using the β-galactosidase assay.  tRNA variant 40A was completely inactive in the 
absence of a functional synthetase, while variant 49A displayed partial activity, 
suggesting it might be interacting with other synthetase machinery expressed by the host 
(data not shown).  
β-galactosidase screening 
 tRNA synthetase variants cloned into pRST.11B backbones were transformed into 
CA274 E. coli cells, which contain an amber codon at position 125 of the LacZ gene.  
Individual colonies were patch plated onto 2xYT media plates containing 100 μg/ml 
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carbenicillin, 40 μg/ml X-Gal (Sigma), and 0.1 mM IPTG, with or without 1 mM 5HTP.  
Cells were grown at 37oC for approximately 6 hours which resulted in visibly blue 
colonies for active synthetases.  
GFP-FACS screening 
 Variants from either synthetase or tRNA libraries were cloned into pRST.11B 
backbones and analyzed via GFP. A FACS optimized variant of GFP, GFP 
mut2(Cormack et al., 1996), was cloned in place of the Taq DNAP open reading frame in 
pACYC-Taq and amber codons were introduced at positions Y39, Y151, Y182(Wang et 
al., 2001), resulting in plasmid pACYC.GFPmut2.3Amb.  E. coli BL21(DE3) were co-
transformed with individual synthetase or tRNA library variants and 
pACYC.GFPmut2.3Amb, and grown overnight at 37oC in 2xYT media.  The following 
day, 10 μl of cells were diluted into 1 ml fresh 2xYT media (containing appropriate 
antibiotics and 5HTP when necessary) and grown for 2 hours at 37oC.  Expression of 
both the synthetase and GFP were induced with the addition of 1 mM IPTG and grown 
for 4 hours at 37oC.  Cells were harvested by centrifugation (4oC) and resuspended in 
phosphate buffered saline.  Fluorescence analysis was performed on either a 
FACSCalibur (BD Biosciences) flow cytometer or on a Safire monochromator (Tecan) 
using GFP fluorescence (Excitation/ Emission 481/507). 
DHFR purification and mass spectrometry  
 E. coli dihydrofolate reductase (DHFR) was used to assess the incorporation of 
the 5HTP amino acid.  Plasmid pACYC.DHFR_V10Amb contains an amber codon at 
V10 of DHFR.  Plasmids pRST.11B, pRST.5HTP, and pRST.5HTP.40A were co-
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expressed with pACYC.DHFR_v10Amb in BL21(DE3).  The strains were grown in 
2xYT media at 37oC until reaching OD600 ~0.7-0.8 at which point 1 mM 5HTP and 1 
mM IPTG were added.  Cells were grown overnight at 30oC. Following induction cells 
were harvested by centrifugation and resuspended in binding buffer (50 mM Tris-HCl, 
pH8.0, 0.5 M NaCl, 5 mM imidazole).  Resuspended cells were lysed via sonication on 
ice using 40% probe amplitude for 2 minutes (1s ON, 1s OFF).  Cell debris was pelleted 
by centrifugation (30min: 20,000g).  The His-tagged DHFR was purified by immobilized 
metal affinity chromatography (IMAC).  The lysate was run over 1 ml (bead volume) Ni-
NTA gravity column pre-equilibrated with binding buffer.  The column was washed with 
10x column volumes of binding buffer, 3x column volumes of wash 1 buffer ( 50 mM 
Tris-Hcl, pH 8.0, 0.5 M NaCl, 20 mM imidazole), and an additional 3x column volumes 
of wash 2 buffer (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 30 mM imidazole).  DHFR was 
eluted off the column by the addition of 4x column volumes of elution buffer (50 mM 
Tris-HCl, pH 8.0, 0.5 M NaCl, 250 mM imidazole).  DHFR samples were centrifuged 
(10min: 16,000g) to remove insoluble protein and then loaded onto a FPLC and 
fractionated by size exclusion chromatography into 10 mM Tris-pH 8.0.  The purest 
DHFR fractions were used for mass spectrometry analysis. 
Top down ultraviolet photodissociation MS 
DHFR (V10Amber) was expressed and purified as described above.  Following 
purification, the proteins were buffer exchanged into LC-MS grade water using 3 kDa 
molecular weight cutoff filters.  The proteins were diluted to 10 µM in a solution of 
50/49/1 MeOH/water/formic acid.  Proteins were infused at a flow rate of 5 µL/min and 
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ionized by electrospray ionization on a Thermo Scientific Orbitrap Elite mass 
spectrometer (Thermo Fisher Scientific) modified for ultraviolet photodissociation 
(UVPD) in the HCD cell as described previously.  A 193 nm excimer laser was used for 
UVPD.  Intact molecular weight measurements at maximum resolution were undertaken 
to confirm the presence or absence of the expected single 5-hydroxy-L-tryptophan 
incorporation.  The site of modification was confirmed using UVPD via a single 5 ns 193 
nm laser pulse.  The UVPD product ion spectra were also acquired at maximum 
resolution. Precursor and product ion spectra were interpreted manually and using the 
Xtract (ThermoFisher) deconvolution algorithm in conjunction with a beta version of 
ProSightPC 3.0. The Sequence Gazer tool was used to assign possible locations of the 
~16 Da observed mass shift.  Incorporation efficiency was calculated by subtracting the 
area of artifactual oxidation (ScWRS - 5HTP control) from the combined areas of the 
5HTrp and singly oxidized 5HTP peaks, and dividing by the summed areas of all peaks 
(Trp, 5HTP, and 5HTP+oxidation).  Peak area integration was performed using the 5 
most abundant peaks for each isotope cluster.  Fold enhancement was calculated by 
comparing the incorporation rates of 5HTP for ScWRS and R3-13.  Incorporation rates 
for each were arrived at by dividing the area of the 5HTP containing peak by the 
combined areas of the 5HTP and naturally occurring reduced Trp containing peaks, and 
then applying a correction to account for artifactual oxidation during sample handling.  
The correction factor was attained by performing the same calculations as above for the 
singly oxidized peak using ScWRS in the absence of 5HTP in the media. 
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Comparison of tRNAs generated by existing methods and CPR 
 Existing approaches for generating orthogonal tRNAs have relied upon an in vivo 
life-death selection system. A recent publication (Chatterjee et al., 2013) used this 
traditional approach to generate optimized versions of the Saccharomyces cerevisiae 
orthogonal suppressor tRNA. To demonstrate the effectiveness of CPR, tRNAs were 
compared to each other for cross-reactivity to the native E. coli translation machinery and 
for amber suppression activity. The optimized tRNAs were cloned into the starting vector 
(sequences of tRNAs: AS3.4; 40A; H13; H14) in place of the AS3.4 tRNA as well as a 
vector containing a non-functional version of the synthetase (to test for tRNA 
orthogonality). The tRNAs (compared to AS3.4 and 40A) are in the AS3.51 background 
with acceptor stem mutations H13 and H14. To test for tRNA cross-reactivity to E. coli 
tRNA synthetases, tRNAs (without active S. cerevisiae aminoacyl tRNA synthetase) 
were expressed with GFPmut2 (Y39TAG; 1Amb), as described above and measured on a 
monochromator. Resulting fluorescence reflects tRNA charging with endogenous E. coli 
machinery and therefore lack of orthogonality. To further test orthogonality, tRNAs were 
transformed into E. coli strain CA274 (LacZ 1Amb). The relative efficiency of amber 
suppression was tested as described above.  
Dynamic range of CPR 
 CPR mixes were processed as described (above) but purified Taq DNA 
polymerase (NEB) was added exogenously. A mixture consisting of an abundance of Taq 
DNA polymerase (0.8 µg; 5.1 x 1012 molecules) and 20 ng (3.8 x 109 molecules) of a 
DNA template "A" was emulsified and added in equal volume to a second emulsion 
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consisting of a variable concentration of Taq DNA polymerase and 20 ng template "B" 
(which is identical to template A but contains an internal Hind III restriction 
endonuclease site). Emulsion PCRs were performed with various ratios of polymerase 
concentrations (A (0.8 µg):B (N µg)). Emulsions were broken, recovery PCR performed, 
and followed by a Hind III digest. The DNA was run on a gel resulting in two distinct 
bands, one corresponding to template A and the other template B. Intensities of template 
A and B were measured (ImageJ), normalized to the equal ratio condition (1:1), and 
plotted. 
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Figure 1.1 : Schematic of general CPR concept.  
a, In the in vivo expression step, E. coli are transformed with genetic circuits or parts 
(partner genes) designed to drive production of Taq DNA polymerase (Taq pol).  The 
partner gene-encoded biomolecules that display an active phenotype (green) produce Taq 
pol while inactive biomolecules (red) do not.  Whole E. coli cells are compartmentalized 
via a water-in-oil emulsion along with primers, dNTPs, and Taq DNA polymerase buffer.  
Emulsions are thermal cycled, leading to E. coli cell lysis and preferential in vitro PCR 
amplification of partner genes that drove production of the most Taq DNA polymerase 
during the in vivo expression step. b, In vivo CPR design for the evolution of orthogonal 
T7 RNA polymerase: promoter pairs. A T7 RNA polymerase library drives the 
expression of Taq pol from a mutant promoter sequence. c, In vivo CPR diagram for the 
evolution of tRNA synthetase:suppressor tRNAs. A tRNA and/or tRNA synthetase 
library suppresses amber codons in the Taq pol gene to generate active polymerase. 
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Figure 1.2 : CPR selection of an orthogonal T7 RNA polymerase.   
a,   Activity of WT T7 RNAP and the CPR-evolved variant CGG-R12-KIRV in E. coli 
cells expressing PT7 and PCGG-driven GFP reporters (top).  Induced cultures were imaged 
with UV transillumination and a digital camera (bottom).  b, Activity of WT T7 RNAP 
and the CPR-evolved variant CGG-R12-KIRV in an in vitro transcription assay using PT7 
and PCGG-driven expression of the spinach aptamer as a readout.  Spinach fluorescence 
was read every minute and plotted as a function of time. c, Activity of several evolved or 
engineered T7 RNAP variants in E. coli cells expressing PT7 and Pcog-driven GFP 
reporters.  Pcog refers to the cognate promoter for the mutant being assayed.  Polymerase 
Cross Reactivity (white) refers to the activity of the mutant T7 RNAP on the WT 
promoter.  Promoter Cross Reactivity (grey) refers to the activity of the WT T7 RNAP on 
the mutant promoter.  Polymerase:Promoter activity refers to the activity of the mutant 
polymerase on the mutant promoter.  Fluorescence was quantified on a Tecan Safire 
monochromator.  The WT pair’s value was defined as 100 in each experiment.  In vivo 
fluorescence was normalized to OD600; fluorescence/OD600 ratio reported is the 
average of three independently grown cultures.  In vitro fluorescence reported is the 
average of three independently assembled transcription reactions.  Error bars represent 




Figure 1.3 CPR evolved 5-hydroxy-L-tryptophan utilizing tRNA synthetase and 
optimized tRNA.   
a, tRNA synthetase variants from rounds of CPR selection were assayed using β-
galactosidase containing a single amber codon with and without supplemented 5HTP in 
the growth media.  b, Deconvoluted intact whole-protein mass spectra of dihydrofolate 
reductase (containing an amber codon at position 10) with wild-type S. cerevisiae 
synthetase (ScWRS) which incorporates tryptophan (expected mass: ~19052) or with the 
evolved 5OH-R3-13 variant which demonstrates the ~16 Da mass shift expected from 
incorporation of 5HTP. c, tRNA amber suppression efficiency was quantitated by the 
ability to suppress 3 amber codons in GFP in conjunction with the wild-type tRNA 
synthetase. The parental AS3.4 and CPR-evolved 40A tRNA are compared by flow 
cytometry, demonstrating the optimized tRNA increases GFP production. d, Amber 
suppression efficiency was quantified via fluorescence by using GFP (3 amber) using the 
5OH-R3-13 synthetase with the parental AS3.4 or CPR-evolved 40A tRNA in the 
presence and absence of supplemented 5HTP.  Fluorescence/OD600 ratio reported is the 





Figure 1.4 : Characterization of 5OH-R3-13 and Specificity Model.  
(A) Wild-type S. cerevisiae  tryptophanyl tRNA synthetase was mutated to contain single 
and double mutations of the 5HTP incorporating synthetase variant 5OH-R3-13 (T107C, 
P254T, C255A). Fluorescence was assayed in E. coli using GFP (1Amb) with and 
without 1 mM 5-hydroxy-L-tryptophan contained in the media.  (B) Bonham projection 
of relative specificity between single, double and triple mutants of 5OH-R3-13.  (C) S. 
cerevisiae tryptophanyl tRNA synthetase binding pocket with 5HTP (yellow) modeled 
into the binding pocket, library residues (cyan) and T127 (magenta). (D) Proposed model 






Figure 1.5 : Optimized tRNA sequence and tRNA libraries.  
 
(Top) Cloverleaf structures and sequences of the orthogonal yeast tryptophanyl AS3.4 
tRNA and the CPR evolved tRNAs (40A and 49A).  (Bottom) tRNA libraries used as 





Figure 1.6 : Taq DNA polymerase abundance and cycle number influence dynamic range 
of selection.  
 
A DNA template "A" was emulsified with an abundance of Taq DNA polymerase and 
mixed, in equal parts, with a separate emulsion containing template "B" with decreasing 
amount of Taq DNA polymerase. Emulsion mixes were thermal-cycled with variable 
numbers of cycles and the enrichment of “A” relative to “B” was determined.     
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Chapter 2: A Legacy Biosensor System Evolved for Allosteric and 
Intramolecular Logic 
 
In this chapter, I describe the use of CPR for the directed evolution of biosensors. 
A single evolutionary "legacy" biosensor from E. coli, the tryptophan repressor (TrpR), 
was evolved and designed to confer a variety of novel responses. The wild-type TrpR 
regulates expression of the enzymes responsible for L-tryptophan biosynthesis by binding 
to a palindromic operator sequence upon allosteric activation by L-tryptophan. Using 
CPR, TrpR was evolved to respond to two novel effectors, 5-bromo-L-tryptophan and 6-
bromo-L-tryptophan, in a specific manner. Biosensors possessing these novel regulatory 
features were then used to evolve novel DNA operator binding specificity, resulting in a 
total of fifteen unique biosensors that each respond to a novel effector molecule and 
operator sequence. In addition, higher-order regulatory architectures were designed by 
the intramolecular fusion of the two monomers that form the TrpR dimer. Tethering 
unique repressor monomers enabled NAND-gated effector logic and modularity of the 
DNA operator sequence, potentially enabling construction of dozens of unique repressor 
phenotypes. 
INTRODUCTION 
  Organisms must dynamically respond to their environment, and intracellular 
contextual cues such as regulation of metabolic pathways, cell cycle progress, or threats 
from foreign viral infections (López-Maury et al., 2008; de Nadal et al., 2011). Cellular 
responses are mounted either by activation of biomolecular complexes or through signal 
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transduction pathways that will ultimately modulate gene expression in response to 
stimulus (Kiel et al., 2010). For instance, allosteric transcription factors (or biosensors) 
fine tune gene expression depending on the concentration of effectors molecule through 
the interplay between conformational folding states and promoter binding (Hilser et al., 
2012; Motlagh et al., 2014). Biosensors have been widely used in synthetic biology for 
developing complex phenotypes like pattern formation, bacterial population behaviors, 
and as a tool for improving metabolic flux (Basu et al., 2005; Chen et al., 2015; Raman et 
al., 2014; Tabor et al., 2009).  
 Synthetic regulatory networks are often constructed from various evolutionary 
contexts or are part-mined from genomic databases (Nielsen et al., 2013). However, this 
may complicate the construction of genetic circuitry. Host context may render parts 
unusable due to cross-reactivity or auxiliary components being required (Rhodius et al., 
2014; Temme et al., 2012). The exact biomolecular functions of parts from metagenomic 
data may also be unknown, requiring laborious efforts to identify function (Moon et al., 
2012; Stanton et al., 2014). In contrast, well characterized and evolutionarily ancient 
parts that have evolved with host machinery are known to function in a predictable 
manner, so called “legacy parts.” Evolutionary theory predicts how legacy parts could 
expand to adopt new phenotypes over time through gene duplication, specialization, and 
recombination (Hughes, 1994; Ohno et al., 1968). Here we examine whether a single 
legacy biosensor system, the tryptophan repressor (TrpR), contains the functional and 
evolutionary plasticity to create diverse regulatory architectures. 
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 The TrpR biosensor is the main regulatory component that governs expression of 
genes from the tryptophan biosynthetic operon in E. coli (Xie et al., 2003). Two TrpR 
monomers undergo dimerization to form an aporepressor complex that will ultimately 
bind two palindromic operator sequences (OWT CTAGTAC).  Increased cellular 
concentrations of the small molecule, L-tryptophan, triggers the complex to bind these 
operators with high affinity, effectively inhibiting gene expression from the PTRP 
promoter by blocking transcription machinery access (Hurlburt and Yanofsky, 1992; 
Yang et al., 1996).  
 To expand the function of the allosteric TrpR biosensor, we utilized CPR which 
we have previously been shown to be a powerful tool for the directed evolution of 
individual parts or circuit function (Ellefson et al., 2014; Meyer et al., 2015). In CPR, the 
in vivo function of a circuit is linked to the expression of a thermostable DNA 
polymerase, Taq, as an output. Individual circuits (transformed into E. coli cells) achieve 
a spectrum of polymerase production based on behavior of library variants. Subsequently, 
up to 109 circuits undergo emulsion PCR – enabling the simultaneous screening of all 
circuits in the library. The most active circuits express the greatest levels of Taq 
polymerase and will subsequently achieve greater amplification in the emulsion PCR – 
allowing in vitro selection over a wide range of circuit operations. The CPR circuit was 
adapted for evolution of the TrpR biosensor to expand its functional capabilites. 
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RESULTS 
Evolving the Trp biosensor for recognition of novel allosteric effectors 
 Allosteric biosensors are complex molecular machines that respond to signaling 
molecules by altering conformations upon binding (Popovych et al., 2009; Reichheld et 
al., 2009; Weaver et al., 2001). Evolving allosteric biomolecules is challenging due to the 
dynamic nature of binding modes, which can be difficult to fully capture during directed 
evolution (Doi and Yanagawa, 1999; Tang and Cirino, 2011; Taylor et al., 2015). We 
chose to alter the binding specificity of the TrpR to respond to halogenated tryptophan 
analogs, 5- or 6-bromo-L-tryptophan (5BrW and 6BrW, respectively), that have been 
implicated in the biosynthesis of neuropharmacological, anti-tumorogenic, and other 
pharmaceutical compounds (Bush et al., 1987; Craig et al., 1997; Efange et al., 1990). A 
number of TrpR mutations are known to cause non-allosteric binding (termed ‘super-
aporepressors’) (Arvidson et al., 1993) – in order to maintain the dynamic response 
mechanism of the TrpR during directed evolution, we modified CPR for both positive 
(binding) and negative (non-binding) selection (Fig. 2.1). Due to the TrpR repressor 
system having a negative functional output (repression of signal), the positive CPR 
selection was performed using an inverter circuit by inhibiting expression of the λCI 
repressor regulating expression of the λPR promoter (Fig. 2.2a). By including the small 
molecule analog during the positive selection, and omission during negative selection, 
repressor variants are enriched that dynamically respond to the effector molecule. 
 Amino acid residues proximal to the 5- or 6-halogenation site were randomized 
using site saturation mutagenesis (NNS randomized) at positions V55, I57, V58, E59, 
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E60 and A50, I57, A77, T81, I82, respectively. Putative allosteric repressor variants were 
placed under the control of a medium strength inducible promoter PLacUV5 in the positive 
selection and constitutively expressed by promoter PCON during the negative selection to 
mitigate leaky expression of Taq polymerase.  Three cycles of positive CPR selection 
were performed – interspersed with four cycles of negative CPR selection (outlined in 
Material and Methods). Small scale screening of repressor variants from both libraries 
identified biosensors capable of responding to 5BrW and 6BrW, and as expected variants 
had lost specificity for L-tryptophan, as no binding signal was detected even on 
tryptophan rich 2xYT media. The 5BrW repressor (5RWT) regulated gene expression 
from the PTrp+  promoter (a higher expression Trp promoter) over a 50-fold dynamic 
range with an EC50 of 17 μM and an EC50 of 79 μM for the inverted circuit (Fig. 2.2d). 
The CPR evolved 6BrW repressor (6RWT) regulated gene expression over a 45-fold 
dynamic range with an EC50 of 53 μM and an EC50 of 171 μM for the inverted circuit. 
Given the tryptophan analogs 5BrW and 6BrW only vary structurally by a single position 
on the tryptophan heterocycle, non-specific repressor variants may have been enriched 
during selection. Surprisingly, small molecule cross-reactivity assays of the biosensor 
variants revealed both were fully orthogonal for their cognate targets (Fig 2.2c). Testing 
with another halogen substitution (5- or 6-chlorotryptophan) revealed the biosensors were 
not specific for bromine, which is unsurprising given the similar atomic properties of 
halogens (Fig 2.3).  
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CPR evolution of novel DNA operator:TrpR interactions 
 After small molecule binding, biosensors alter conformations to promote binding 
or dissociation from cognate DNA operator sequences. To determine if altered DNA 
binding specificities are compatible and as facile to evolve as the allosteric binding site, 
we next attempted to alter the DNA operator specificity of the TrpR biosensors. Upon 
small molecule effector binding and subsequent dimerization, the TrpR natively binds 
two palindromic operator sites near the -10 region of the promoter (Otwinowski et al., 
1988). Since variation of the DNA operator site will influence promoter strength, we 
screened several candidate operator sequences and identified four additional operators 
that did not inactivate the promoter (Fig. 2.4). The identified operator sites (O1, OA, OB, 
OD) had higher expression than the native PTRP promoter and were repressed negligibly 
by the wild-type TrpR. These operators were cloned into the promoter driving the 
expression of the λCI repressor for positive selection CPR. Randomization of residues 
directly contacting the promoter were made on the 5RWT and 6RWT scaffolds at positions 
K72, G78, I79, A80, T83 for operators O1 and OD and Q78, R69, K72, G78,I79, A80, 
T83 for operators OA and OB (Fig. 2.5a).  
 Three rounds of positive selection CPR were performed, which narrowed the 
library sufficiently for screening. Sequenced variants showed convergence towards 
specific amino acid motifs, presumably to allow binding to the new operator sites. For 
instance, evolution of the biosensors for OD resulted in a perfectly matching DNA 
binding domain mutations K72S, G78C, I79C, A80L, and T83R. This commonality was 
not observed for each of the selections, OA variants contained many relatively large 
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differences which may be explained by the 6-bromo repressor containing mutations 
directly adjacent to the DNA library residues – precluding certain amino acid 
combinations. Biosensor variants were tested for promoter repression with the 5BrW or 
6BrW effector molecules (Fig 2.5b). On their cognate operator sequences, the variants 
(termed R subscript cognate operator; e.g. “R1”) displayed a range of repression activity, 
most repressing over 20-fold with addition of the appropriate effector small molecule.  In 
addition, all of the DNA binding motifs from the 5-bromo selections could be 
transplanted on the wild-type binding pocket except for the motif for operator OD, which 
was later selected independently using CPR. In general, the biosensors respond 
specifically to the their cognate effector. However, the operator variants from the 6BrW 
responsive biosensors displayed variable levels of activation with 5BrW. This may be 
due to the amino acid residues comprising the small molecule effector pocket and the 
amino acids involved in DNA recognition having overlap in the 6BrW biosensor 
libraries, but not the 5BrW libraries. To overcome this in the future the opposing small 
molecule could be included in a negative selection CPR step that would eliminate cross 
reactive variants. 
 Using CPR we functionally expanded a single starting legacy biosensor to contain 
fourteen novel phenotypes. To demonstrate their ability to specifically modulate gene 
expression based on the parameters they were evolved for, all 15 biosensors were tested 
for orthogonality for both DNA operator binding specificity, as well as, small molecule 
effector recognition (Fig. 2.5c). Across functional DNA and effector space, the repressors 
were modular despite not including a negative selection CPR step during their evolution. 
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Several notable exceptions were the RA biosensor repressing the OWT (~6-fold), 6R1 
repression (~7-fold) with 5BrW on its cognate operator, and 6RA repressing (~5-fold) 
with 5BrW on its cognate operator sequence. These off-target effects could likely be re-
tuned, for instance by lowering effector concentrations below 1 mM. Nonetheless, this 
degree of orthogonality is surprising, especially as the set was evolved from a single 
evolutionary legacy part and only a handful of mutations are required to drastically 
change phenotype. However, to equip a single cell with multiple different biosensor 
phenotypes the molecular assembly of the repressor dimer poses a challenge to 
maintaining the desired logic functions. 
Design of allosteric and intramolecular logic biosensors 
 CPR based directed evolution of orthogonal biosensors identified a suite of 
repressor variants, each with different molecular logic functionalities. However, 
coexpression of repressor subunits would likely result in the breakdown of desired logic – 
as assembly of the active dimer complex will occur randomly. This logic interference 
prevents higher order regulatory architectures from being constructed in a single chassis. 
To overcome this limitation, we developed a system for the allosteric and intramolecular 
(A.I.) logic of biosensors. Dimers are engineered for orthogonality by redesigning the 
dimer interface, as well as, covalent linkage (or "tethering") by expressing the two 
monomers as a fusion protein. The biosensor A.I. logic system, using the TrpR repressor 
as a scaffold, results in NAND based logic – as repression conditions for both monomers 
must be met for both half-sites to actively regulate promoter expression. 
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 Initial efforts to develop the biosensor A.I. logic system involved reengineering 
the dimerization interface of the TrpR protein. The TrpR codons were randomized at 
positions W19, V23, H35, and L39, which have been implicated as key residues involved 
in the folding pathway of the TrpR dimer (Miño et al., 2013; Royer et al., 1993; Shao et 
al., 1997). Three rounds of positive selection CPR were performed to identify dimer 
regions that still resulted in an active repressor complex (Fig. 2.6). Screening variants 
from the resulting selection demonstrated that many possibilities exist as viable 
interfaces. Combinations of interfaces were constructed to guide the correct folding of 
dimers, with emphasis placed on creating steric clashes between non-cognate dimers. 
While we found that some interface regions could be programmed, this would be 
challenging without further mutating additional interface regions. In addition, we 
reasoned this approach is unlikely to be scalable – as each additional repressor interface 
would need to be orthogonal. 
 Based on the crystal structure of the TrpR dimer (PDB: 1RCS), we noticed the C-
terminal amino acid was in proximity to the N-terminal of the second monomer. Circular 
permutation of the two monomers may promote intramolecular folding of proteins and 
provide a scalable solution to avoiding logic interference (Fig. 2.7). Repressors were 
tethered by creating a linker sequence between the two monomers (Material and 
Methods). This approach was combined with our best interface library variants to ensure 
that cross dimerization did not occur between tethered repressors. Additionally, the DNA 
sequences of two halves of the tethered biosensors were recoded to limit homology and 
possible recombination. 
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 Biosensor A.I. logic was validated by using the 5RWT and 6RWT mutants against 
the wild-type operator site (OWT). Monomers expressed bicistronically demonstrated 
logic interference by responding independently to both signaling effector molecules (Fig. 
2.7b). The A.I. biosensor, displayed NAND logic – repressing over 50-fold only when 
both 5BrW and 6BrW were present in the growth media. This demonstrates both halves 
of the tryptophan repressor must be in a conformationally active state in order to achieve 
biologically relevant binding affinity to the operator sites and subsequent promoter 
repression. 
 Theoretically, A.I. biosensor logic should also extend to the DNA binding 
specificity of both halves of the tethered dimer. To demonstrate this, tethered 
combinations of repressors R1 and RB were tested for their ability to repress hybrid 
promoter sequences with operator sequences (O1:O1, OB:OB, and O1:OB). In agreement 
with the previous finding that A.I. logic was dependent on correct logic for both 
biosensor halves, the DNA binding variants must match both operator recognition sites in 
order to bind and represses promoter function (Fig. 2.7c). We found that there was 
variable repressor activities of the hybrid TrpR variants, ranging from high repression 
(>50-fold) to modest repression (~8-fold). However, this may due to the differences in 
promoter strength that resulted from hybrid DNA operator sequences. Despite this, each 
DNA based A.I. logic biosensor was specific for the given operator site pairs and 
required no additional engineering to achieve modularity. 
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DISCUSSION 
Advantages of A.I. logic gated biosensors 
 Functional biosensors are of ever increasing interest, as accurate measurements of 
intramolecular or extracellular signals can be used for real time monitoring of metabolic 
flux or even the directed evolution of metabolic pathways (Raman et al., 2014; Rogers et 
al., 2015). This is especially valuable for measuring signals that do not have a visible or 
growth phenotype, or regulating genes that can dynamically respond to the contextual 
environment – such as degradation of a contaminant (Chen et al., 2014; Yoshida et al., 
2016). Here, we demonstrate complex signaling behaviors can be developed, such as 
cellular logic based A.I. biosensors. Biosensors that perform logic-gated function 
intramolecularly, at the protein function level, may have specific advantages over 
traditional transcription regulated gene networks. In particular, transcriptional networks 
can be slow to respond – having to cascade a signal through multiple stages especially in 
low nutrient conditions (Hooshangi et al., 2005; Rosenfeld and Alon, 2003). Some 
systems have overcome the temporal barrier by relying on protein degradation instead of 
transcriptional activation which can respond more quickly (Prindle et al., 2014). 
However, the logic functions of A.I. biosensors respond entirely at the protein level, and 
signal output can be directly tied to DNA binding affinity (Alonso et al., 2015). The 
evolved TrpR components may also be useful for studying the in vivo dynamics of the 
TrpR regulatory system, as most studies have relied on amino acid depletion in minimal 
media which alters cell physiology due to starvation conditions and traces of L-
tryptophan will always remain (Klig et al., 1988). 
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The evolutionary plasticity of a single legacy biosensor 
 The functional expansion of a single legacy biosensor, TrpR, to contain fifteen 
unique responses – binding to various small molecule signals and DNA operator sites – 
speaks to the evolutionary plasticity of regulatory elements. The malleability of this 
repressor protein demonstrates that organisms can evolve to adapt to a wide variety of 
environmental signals and mount unique and orthogonal responses. The creation of A.I. 
biosensors gives a plausible evolutionary path to higher order regulatory architectures 
through the recombination of gene duplication and recombination of biosensors 
(Teichmann and Babu, 2004).  
MATERIALS AND METHODS 
Validation of vectors for biosensor based positive and negative selection CPR 
 Biosensor based positive and negative selection vectors were constructed using 
overlapping DNA oligonucleotides (IDT) and standard cloning procedures. The pTrpR 
expression and library plasmids were constructed from a ColE1 ori, ampR, and LacIQ 
expression plasmid under the control of either a PLacUV5 inducible promoter (used for 
positive selection CPR and functional assays) or a strong constitutive promoter PCON (for 
negative selection CPR). The selection vectors pPOS and pNEG were constructed from a 
p15A ori, camR, and LacIQ expression plasmid (pACYC-solo). The pPOS plasmid uses 
the wild-type Trp promoter to drive expression of the λCI-LVA degradation tagged 
repressor. The promoter λPR drives expression of either GFP (for screening) or Taq 
polymerase (for positive selection CPR), thus creating an inverter circuit for Trp 
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biosensor function. The pNEG plasmid uses the wild-type Trp promoter to directly drive 
the expression of GFP (for screening) or Taq polymerase (for negative selection CPR). 
 Both selection plasmids (pPOS and pNEG) were functionally tested by expression 
of GFP under active or repressed conditions. To test this, PLacUV5 drove expression of 
either a functional TrpR or an inactive TrpR (truncated by two TAA stop codons and 
containing a unique internal HindIII restriction site; plasmid pTrpR.2TAA). To test 
positive or negative selection CPR, these control constructs were co-transformed with the 
Taq expressing pPOS or pNEG vectors. A single round of CPR selection was performed 
(detailed below) for both positive and negative selections using various ratios of active or 
inactive repressor (1:10 to 1:10,000). Under these conditions, positive selection should 
enrich for active TrpR repression, while negative selection should enrich for inactive 
TrpR repressors. Following selection, CPR derived amplicons were digested with HindIII 
for 2 hours to allow digestion of the internal HindIII site present in the inactive TrpR 
control vector (pTrpR.2TAA). The enrichment factor for positive selection was estimated 
to be roughly 300-fold per round of CPR, while the negative selection was estimated to 








Where (Xinitial/Yinitial) is the initial ratio of active or inactive repressor, EF is the 
enrichment factor, and (Xfinal/Yfinal) is the ratio of active or inactive repressor - post-CPR 
selection. 
 73 
CPR directed evolution of biosensors 
 TrpR repressor libraries were created through site-saturation mutagenesis using 
degenerate oligonucleotides with NNS or NDS codon randomization (IDT). Libraries 
were cloned into an ampicillin resistant; ColE1 origin plasmid that contained the IPTG 
inducible lacUV5 promoter.  Libraries were electroporated into E. coli strain JW4356 (a 
tryptophan repressor knockout strain) pre-transformed with either the positive or negative 
selection vector. Initial library sizes were above the theoretical diversity threshold (~3.0 x 
107) and were maintained throughout the CPR selection with a transformation efficiency 
of at least 106, but more typically 107-108. Overnight library cultures were seeded at a 
1:20 ratio into fresh 2xYT media supplemented with 100 µg / mL ampicillin, 34 µg / mL 
chloramphenicol, and 1 mM of 5-bromo-L-tryptophan or 6-bromo-L-tryptophan, when 
necessary.  Cells were grown for 1 hour at 37°C. Cells were subsequently induced by the 
addition of 1 mM IPTG and incubated at 37°C for an additional four hours.  
 Induced cells (200 µL total) were spun in a tabletop centrifuge at 3,000 x g for 8 
minutes. The supernatant was discarded and the cell pellet was resuspended in CPR mix: 
1x Taq buffer (10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgSO4), 260 µM 
dNTPs, 530 nM forward and reverse CPR selection primers. The resuspended cells were 
placed into a 2 mL tube with a 1mL rubber syringe plunger and 600 µL of oil mix (73% 
Tegosoft DEC, 7% AbilWE09 (Evonik), and 20% mineral oil (Sigma-Aldrich)). The 
emulsion was created by placing the cell and oil mix on a TissueLyser LT (Qiagen) with 
a program of 42Hz for 4 minutes. The emulsified cells were thermal-cycled with the 
program: 95°C - 3min, 25x (95°C - 30 sec, 55°C - 30 sec, 72°C - 1 min). Emulsions were 
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broken by spinning the reaction (10,000 x g - 5 min), removing the top oil phase, adding 
150 µL of H2O and 750 µL chloroform, vortexing vigorously, and finally phase 
separating in a phase lock tube (5Prime). The aqueous phase was cleaned using a PCR 
purification column which results in purified DNA, including PCR products as well as 
plasmid DNA. Subamplification with corresponding outnested recovery primers ensures 
that only PCR fragments are amplified. Typically, this is achieved by addition of 1/10 the 
total purified DNA using Accuprime Pfx (ThermoFisher) in a 20 cycle PCR, however 
challenging rounds of selection could require increasing the amount of template DNA or 
cycle number to achieve detectable amplification. Resulting DNA products were re-
cloned into the selection vector - completing one full round of CPR selection. 
Evolution and functional assays of allosteric repressors 
 Amino acid randomized libraries (NNS codon) were constructed by overlap 
extension PCR and cloned into the pTrpR.2TAA plasmid for positive selection. For the 
5-bromotryptophan library, amino acids: V55, I57, V58, E59, and E60 were randomized. 
For the 6-bromotryptophan library, amino acids: A50, I57, A77, T81, and I82 were 
randomized. Libraries underwent positive selection CPR by co-transformation with the 
pPOS selection vector and supplemented with 1 mM of the corresponding tryptophan 
analog in the media. Subsequently, variants amplified from round 1 were cloned into the 
pTrpR.CON.2TAA vector, which utilizes a constitutive promoter to drive the repressor 
variants during the negative selection. The variants underwent negative selection CPR by 
co-transformation with the pNEG plasmid. Omitting the tryptophan analogs during the 
negative selection CPR counter-selects for variants which bind to the Trp promoter 
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without the analog, thereby repressing Taq expression. The entire selection process was 
completed in 7 total rounds, in the following order: positive (rounds 1, 4, and 7) and  
negative (rounds 2, 3, 5, 6).   
 Tryptophan analog responsive variants, 5BrRWT and 6BrRWT, were transformed 
into JW4356 E. coli cells. Depending on direct or inverted circuit screening architecture, 
these were co-transformed with either pNEG+.GFP (expressing GFP with Trp+ promoter 
with enhanced expression) or pPOS.GFP for an inverted signal. Overnight cultures of 
individual colonies were seeded into a 96-well grow block containing 2xYT 
supplemented with ampicillin, chloramphenicol, and 1 mM IPTG at a 1:20 dilution ratio. 
Wells contained the indicated concentration of either 5-bromo-DL-tryptophan (Sigma) or 
6-bromo-DL-tryptophan (Gold Biotechnology). Cells were incubated for 5 hours at 37°C 
to allow expression of repressors and GFP. Prior to fluorescence measurement on a plate 
reader (Tecan M200, excitation 469 nm; emission 501 nm), cells were centrifuged at 4°C 
for 20 minutes at 3,000 x g and resuspended in 1x PBS solution. Fluorescence intensities 
were measured and normalized to the OD600 of the culture. Non-fluorescent JW4356 cell 
fluorescence was subtracted from all samples, which was calculated by the fluorescence 
divided by OD600 for the parental JW4356 strain. Maximal signal output was calculated 
by transformation of a control vector - with  wild-type TrpR (for inverter circuit), or 
inactivated TrpR (for repression circuit). 
 To calculate the half maximal effective concentration (EC50) for repression, the 





where (c) is the EC50 of 5- or 6-bromo-DL-tryptophan (mM). 
 To calculate the EC50 for activation (inverter circuit), the dose-response function 




where (b) is the EC50 of 5- or 6-bromo-DL-tryptophan (mM). 
Screening of Trp promoters with novel operators 
Novel operator sites were designed by mutating palindromic operator sites at 
conserved binding residues except for the +1 and +2 positions of the (CTAGTAC) wild-
type operator sequence. These residues were avoided because they form part of the core 
of the Trp promoter's -10 region (Pribnow box) and would likely influence promoter 
activity. Mutant operators focused heavily on mutation of the +3, +4, +5, and +7 
positions of the operator due to the phylogenetic conservation of sequences at these 
positions and the clear contacts that are made with the repressor itself. These mutant 
operators were placed into the wild-type Trp promoter and tested for activity. GFP 
expression with a truncated TrpR (2TAA) repressor indicated the total promoter strength 
of the mutant operators  driving the expression of GFP. Operators were also tested for 
their orthogonality to the wild-type repressor by co-testing with the TrpR under the 
expression of a high strength tac1 promoter. Candidate operator sites were chosen based 
on promoter activity and orthogonality to the wild-type repressor. 
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Evolution and functional assays of novel operator binding 
 Amino acid randomized libraries (NDS codons) were built on top of the 5BrRWT 
and 6BrRWT scaffold sequences. For operator 1 and operator D (O1 or OD) libraries, 
positions K72, G78, I79, A80, and T83 were NDS randomized. For operator A and 
operator B (OA or OB), two libraries were used. The first library was NDS codon 
randomized at positions Q68, R69, K72, I79, A80, and T83. The second was NDS codon 
randomized at positions Q68, R69, G78, I79, A80, and T83 with K72S mutation. 
 The positive selection vector, pPOS, was modified so the Trp promoter driving 
expression of the λCI repressor contained mutant palindromic operator sites. TrpR 
variants that most effectively bind the novel DNA operator sequences will down-regulate 
the λCI, which subsequently increases expression of Taq polymerase. Positive CPR 
selection was utilized using the previously described methods, and contained 1 mM of 
either 5BrW or 6BrW. The libraries underwent three (for O1 and OD) or four (for OA and 
OB) rounds of positive CPR selection prior to functional screening. To create the L-
tryptophan binding repressor with altered DNA operators, the corresponding 5BrR 
variant mutations were placed into the wild-type binding pocket. This created highly 
functional repressors, except in the case of OD. To obtain this variant, an independent 
CPR selection was done on the wild-type scaffold with K72, I79, A80, and T83 fully 
(NNS) randomized. After three rounds an OD binding variant was obtained. 
 Plasmids with variant repressors were transformed in E. coli JW4356 along with 
plasmids encoding the Trp promoter driving GFP, regulated by the cognate operator 
sequences. Overnight cultures were seeded into a 96-well grow block containing 2xYT 
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supplemented with ampicillin, chloramphenicol, and 1 mM IPTG at a 1:20 dilution ratio. 
If indicated, 1 mM 5BrW or 6BrW was added to the growth media. Cells were grown for 
6 hours at 37°C and subsequently processed and measured as previously described. Non-
fluorescent JW4356 cell fluorescence from non-GFP expressing JW4356 cells was 
subtracted from experimental samples. Maximal promoter output was calculated by a 
control experiment transformed with inactive TrpR (TrpR.2TAA) that expresses a 
premature stop codon in the coding sequence. 
 The orthogonality of all repressor and operator combinations was performed as 
described above. All fifteen repressors were transformed into cells containing each of the 
five operator (OWT, O1, OA, OB, or OD) PTrp promoters. These were either grown in 
conditions with 2xYT media (high concentration tryptophan media), 1 mM 5-bromo-DL-
tryptophan, or 1 mM 6-bromo-DL-tryptophan. Fold repression was calculated by dividing 
the fluorescence of the maximal promoter strength by the fluorescence of the 
experimental condition.   
Construction of biosensor driven allosteric and intramolecular logic 
The TrpR interface was engineered by randomization (NNS) of positions between 
the interface of the dimers, followed by three rounds of positive CPR selection. The 
positions randomized were: W19, V23, H35, and L39. In the wild-type repressor, 
positions W19 and V23 of the first monomer directly interact with positions H35 and L39 
of the second monomer. Between the dimer, two regions comprise the interface which 
theoretically can be engineered to prevent monomers from self-dimerization. Screening 
of TrpR interface variants and sequencing revealed many viable combinations of amino 
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acids that result in an active repressor. One variant, Int.3 (W19L, V23M, H35D, and 
L39W), was of particular interest because the large hydrophobic tryptophan residue 
(which has been shown to be an essential component of the folding pathway of the dimer) 
had translocated orientations, to the opposite side of the interface. Monomers could be 
programmed with the two tryptophan residues sterically clashing between mismatched 
monomers, thus preventing folding and dimerization. This resulted in the following 
combinations of amino acids W19, V23, D35, W39 for the first monomer and L19, M23, 
H35 and L39 for the second. 
TrpR repressors were tethered by fusion of the two monomers using circular 
permutation. The last aspartate residue (D108) of the first monomer was deleted and the 
N-terminal fifteen amino acids of the second monomer was also deleted. The deletion of 
residues was performed to prevent (1) inadvertent translation initiation at residue M11 
and (2) long flexible linkers can be targets for proteolysis. Either of these would result in 
non-tethered repressors, that could potentially disassemble and reassemble with other 
repressor monomers. In addition to the deletion of these residues, screening of a small (4 
amino acid) linker was performed to identify residues that may promote intramolecular 
folding of the two monomers. Linker libraries contained 4 NNS codons and were 
screened for functional repressor activity. The linker region His, Arg, Phe, Asn was used 
for all fusion proteins.  
Functional testing of tethered 6BrRWT and 5BrRWT repressor constructs was 
carried out by a GFP assay using repression of the wild-type Trp promoter. Cells were 
induced for 7 hours with 5 mM of 5- or 6-bromo-DL-tryptophan and 1 mM IPTG. Cells 
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were handled as described previously before fluorescence measurements. For DNA 
operator tethering, synthetic Trp promoters were created by combinations of the operators 
O1 and OB to create (O1:O1, OB:OB, and O1:OB). These were co-transformed with tethered 
DNA repressor variants: R1-R1, RB-RB, or R1-RB. Cells were induced with IPTG for 5 




Figure 2.1 : Validation of positive and negative CPR for biosensor evolution. 
Circuits for the evolution of biosensors are outlined above.  The pTrpR plasmid contains 
an active or inactive version (2TAA) of wild-type tryptophan repressor (TrpR). This 
plasmid is co-transformed with biosensor selection vectors, pPOS (for positive selection 
CPR) or pNEG (for negative selection CPR). Selection vectors were validated with GFP 
substituted for Taq polymerase, and assayed for fluorescence with an active or inactive 
TrpR. Mock CPR selections were carried out by mixing active and inactive repressors (at 
the ratio indicated) and performing a single positive or negative CPR round. Resulting 
products were size separated and final post-selection ratios were estimated to yield an 





Figure 2.2 : Selection and characterization of a 5- and 6-bromotryptophan repressor. 
a, Halogenated tryptophan responsive repressors were selected by performing rounds of 
biosensor positive or negative selection CPR. In positive selection CPR, the desired small 
molecule is added to the media and biosensors that actively suppress λCI expression are 
enriched. In negative selection CPR, the desired small molecule is omitted from the 
media and biosensors that are non-specific will inhibit Taq polymerase production. b, 
Molecular structure of 5-halo-tryptophan and 6-halo-tryptophan. c, Evolved biosensors 
for 5-halogenated or 6-halogenated tryptophan are orthogonal, however will respond to 
bromo or chloro modifications indiscriminately. d, Dose-response functions of the 5-halo 
and 6-halo biosensors with either 5-bromo-DL-tryptophan or 6-bromo-DL-tryptophan, in 




Figure 2.3 : Characterization of evolved biosensors repression and cross-reactivity.  
The wild-type TrpR (RWT), inactive TrpR (R2TAA), 5-halo (5RWT), and 6-halo (6RWT) 
repressors were characterized for in vivo repression with tryptophan (2xYT), 5-bromo 
(5BrW), 5-chloro (5ClW), 6-bromo (6BrW), or 6-chloro (6ClW) tryptophan analogs (at 1 
mM final concentration). Repression efficiency was either measured in a direct biosensor 
circuit or inverted biosensor circuit architecture by measurement of the relative 




Figure 2.4 : Identification of novel operator sites that are active and orthogonal. 
Potential orthogonal operator sites were designed by mutating conserved residues and 
residues with obvious contacts to the TrpR protein. Additionally, the +1 and +2 sites of 
the operator were not changed since they constitute part of the Pribnow box. Candidate 
operator sites were cloned into the pNEG vector construct and tested for promoter 
expression of GFP. These were tested with both active wild-type and inactive repressors, 
to identify operators that resulted in strong promoters and were relatively orthogonal to 





Figure 2.5 : Evolution and characterization of biosensors responsive to novel operators. 
a, CPR scheme for the directed evolution of novel operator recognition and repression. 
Orthogonal operator sites (O1, OA, OB, OD) are inserted into the positive selection CPR 
circuit by swapping the promoter driving the expression of the λCI protein. Biosensors 
capable of binding the operator sites and blocking transcription initiation will produce 
Taq polymerase more effectively. b, Evolved biosensor variants (annotated R1 for the 
tryptphan responsive operator 1 binding variant, 5R1 for the 5-bromo-tryptophan operator 
1 binding variant, etc.) were tested for GFP repression activity on their cognate operator 
sites with 2xYT, 1 mM 5-bromo-tryptophan, or 1 mM 6-bromo-tryptophan. c, All fifteen 
biosensors were tested for against each operator sequence and tryptophan analog 
condition. A heatmap of repression activity was generated by calculating the fold 
repression for each biosensor in each experimental condition.  
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Figure 2.6 : Design and selection of a dimerization interface on the TrpR 
In the top panel, a structural model of the TrpR dimer is shown. For clarity, one monomer 
is labeled yellow and the other blue. Residues involved in a critical region of the dimer 
are labeled. These residues were randomized and underwent three rounds of positive CPR 
selection. Novel interface residues were identified by their ability to repress the Trp 
promoter. Interface residues were reprogrammed to result in steric clashing between 




Figure 2.7 : Design of A.I. logic gated biosensors  
a, A design method for the higher order assembly of genetic architecture with evolved 
biosensor components. Coexpression of evolved monomers results in logic interference 
due to random dimerization and subsequent hybrid phenotypes. Tethering of repressor 
monomers by intramolecular fusion ensures correct folding of biosensors, and prevents 
logic interference. b, A.I. logic enables protein-level NAND effector logic. Fusion of the 
6RWT and 5RWT biosensors creates a NAND gate, requiring both 5-bromo-tryptophan and 
6-bromo-tryptophan to repress expression from the wild-type Trp promoter. c, A.I. logic 
enables modular swapping of DNA recognition domains. Combinations of R1 and RB 




Chapter 3:  Synthetic Evolutionary Origin of a Proofreading Reverse 
Transcriptase 
 While proteins involved in fundamental biological processes are under 
extraordinary functional constraints, recent work has shown that core components in the 
central dogma can be engineered to have radically altered properties, such as the creation 
of expanded genetic alphabets, tethered ribosomes, and rewiring of the genetic code 
(Lajoie et al., 2013; Malyshev et al., 2014; Orelle et al., 2015).  One of the last discovered 
components of the central dogma, reverse transcriptase (RT), has for the most part been 
the province of a single family of enzymes of ancient evolutionary origin and are 
inherently error prone due to their lack of a proofreading (3'- 5' exonuclease) domain. To 
determine if the lack of proofreading is a historical coincidence or a functional limitation 
of reverse transcription, we attempted to  evolve a high fidelity, thermostable DNA 
polymerase to efficiently use RNA templates. The Reverse Transcription 
Xenopolymerase (RTX) is a new, distinct evolutionary lineage that maintains the DNA 
proofreading activity of its parent with a RNA template, which was shown to greatly 
improve RT fidelity. Mutations in highly conserved molecular checkpoints render RTX 
capable of polymerizing either DNA or RNA templates with similar efficiencies, 
enabling applications such as single enzyme RT-PCR and direct RNA sequencing 
without cDNA isolation. The creation of RTX confirms proofreading is compatible with 
reverse transcription and reemphasizes that core molecular machinery that has otherwise 
been conserved over billions of years can be engineered to attain novel functionality. 
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INTRODUCTION 
 The molecular basis for all life rests on the information flow between DNA, 
RNA, and proteins (Crick, 1970). Early notions of how information was processed was 
amended after Temin and Baltimore's discovery of the reverse transcriptase (RT) enzyme 
(Baltimore, 1970; Temin and Mizutani, 1970) - clashing with the generally accepted view 
of a unidirectional central dogma. Evolutionary studies have elucidated that the RT 
family has a single ancient evolutionary origin which is supported by conserved amino 
acid homology and the ubiquitous presence of RT across multiple domains of life (Xiong 
and Eickbush, 1990). RT is hypothesized to be the catalyst in the transition of the RNA to 
DNA world by providing an avenue to copy RNA into more stable DNA genomes 
(Darnell and Doolittle, 1986), but has since found a variety of functional roles in biology 
including: telomere addition, mitochondrial plasmid replication, transposition, and the 
proliferation of retroviral genomes (Boeke and Stoye, 1997).  
 The progenitor of RT is postulated to be an RNA dependent RNA polymerase.  
Since RNA polymerases generally lack an error-checking 3'-5' exonuclease domain 
(Nakamura, 1997; Xiong and Eickbush, 1990), proofreading activity is also not present 
across the RT family, resulting in low fidelity reverse transcription and characteristic 
quasispecies behavior in organisms that rely upon it for replication (Meyerhans et al., 
1989). In contrast to reverse transcriptases, other DNA polymerase families have evolved 
exquisite proofreading mechanisms to increase DNA synthesis fidelity during genome 
replication (Kunkel and Bebenek, 2000). Given this dichotomy, it is unclear whether the 
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lack of proofreading by RTs is due to historical coincidence or whether reverse 
transcription is mechanistically incompatible with proofreading. 
 In order to determine whether the evolutionary divide between RTs and DNA 
polymerases is a matter of history or function, we have attempted to directly evolve a 
reverse transcription xenopolymerase (RTX; Fig 3.1) from an error correcting DNA 
polymerase using a modified directed evolution strategy (Ghadessy et al., 2001), called 
reverse transcription compartmentalized self replication (RT-CSR) (Fig 3.1). RT-CSR 
enables the simultaneous screening of up to 109 polymerase variants for reverse 
transcriptase activity. Briefly, E. coli cells containing a library of putative RTX variants 
are physically compartmentalized through a water-in-oil emulsion and subsequently PCR 
cycled. Primers are included in the emulsion to facilitate self-replication, but contain 
RNA residues which behave as a template in subsequent cycles of PCR to enforce reverse 
transcriptase activity. 
RESULTS 
RT-CSR and Evolution of the Reverse Transcriptase 
 We chose the Archaeal Family-B DNA polymerases (polB) as a starting point for 
directed evolution of the RTX as they are monomeric, hyper-thermostable, highly 
processive, and contain robust proofreading domains – prized tools for modern PCR 
applications. Previous studies have attempted to rationally design these enzymes to utilize 
RNA templates with limited success (Jozwiakowski and Connolly, 2011; Moser et al., 
2012), and initial experiments confirmed that two common polB enzymes from P. 
furiosus and T. kodakarensis (KOD) (Lundberg et al., 1991; Takagi et al., 1997) failed to 
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polymerize across even five template RNA bases. Initial modeling to identify mutations 
enabling RT activity was considered, but deemed impractical given the extensive contacts 
these polymerases make with the template (over 50 direct interactions). We initiated 
evolution using low stringency RT-CSR (10 RNA residues) with a purely random library 
(1-2 amino acid mutations per gene) of KOD polymerase variants. As polymerases were 
enriched, we gradually increased the stringency of RT-CSR by the stepwise addition of 
RNA into primers. By cycle 18, maximum stringency was achieved as primers were 
entirely composed of RNA -  requiring reverse transcription of 176 residues to occur 
every thermal-cycle in order to maintain exponential amplification in the emulsion PCR.  
 Following RT-CSR, profiling of variants revealed extensive mutations throughout 
the polymerases, as over one thousand PCR cycles were performed since the initial 
library was introduced. One particular variant, B11, contained 37 mutations. As expected 
RT-CSR enriched for RT activity and B11 was capable of reverse transcription of at least 
500 base pairs, however sequencing and testing confirmed inactivation of the 
proofreading domain (Fig. 3.2). Kinetic analyses established B11 utilizes both DNA and 
RNA templates with similar efficiencies by greatly lowering the Km on RNA:DNA 
heteroduplex. We attempted to restore proofreading by transplantation of the wild-type 
3'-5' exonuclease which reactivated proofreading capabilities, albeit to barely detectable 
levels. Encouraged that minimizing extraneous mutations intrinsically derived from the 
RT-CSR process could restore proofreading, we sought to design polymerases with a 
minimal core set of mutations. 
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Identification of Mutations involved in Reverse Transcriptase Activity 
 To understand how our process reshaped KOD polymerase to utilize RNA 
templates, we deep sequenced RT-CSR cycles to recapitulate the evolutionary path to RT 
activity (Fig. 3.3 and Table 3.1). Mutations were identified throughout the template-
polymerase interface, but interestingly conserved mutations accumulated precisely as the 
polymerase encounters residues in the template strand. Polymerases contained mutations 
that were hypothesized to be molecular checkpoints used to enforce strict DNA template 
utilization: (1) as the template enters, (2) near the active site, and (3) at the nascent 
duplex. Given the likely importance of these regions, we used computer modeling to 
determine the molecular basis for RNA utilization.  
 The first evolved mutation localized near the template entry site of the polymerase 
at position R97 (Fig. 3.3). Proximal to this site, native polB scans for uracils (typically 
caused by cytosine deamination) by flipping template bases into a specialized pocket to 
halt polymerization until the mutation can be corrected by repair machinery (Fogg et al., 
2002; Greagg et al., 1999). Evolved polymerases contained a variety of amino acid 
mutations to R97, all of which destabilize a salt bridge to the phosphate backbone that 
presumably regulates base flipping into the pocket.  
 As template residues near the active site, they encounter the most conserved RT-
CSR mutation, Y384H, which prevents Y384 and Y494 from hydrogen bonding to the 2' 
hydroxyl of template RNA by reorganizing a hydrogen bonding network. Post 
polymerization, in the thumb domain, the most prevalent mutations (E664K, G711V, and 
E735K) promote tighter homo and hetero duplex binding in both A and B-form 
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conformations. Previous studies support this hypothesis and have shown that the E664K 
mutation alone causes markedly increased binding to RNA:DNA heteroduplexes (Cozens 
et al., 2012). To further validate we established an optimized set of mutations, we fully 
randomized (NNS library) several positions and repeated RT-CSR. In support of our 
modeling, many amino acids solutions were viable at position R97, but other positions 
(namely, Y384 and E664) had strong preferences for particular amino acids. 
Design of the First Proofreading Reverse Transcriptase  
 Modeling driven designs of several polymerases with favorable RT mutations 
were synthesized and empirically tested. Our most promising RTX contained less than 
half the mutations of B11, without sacrificing catalytic efficiency or Km on RNA (Fig. 
3.4). Mutations in RTX were demonstrated to not negatively affect desirable properties of 
parental KOD polymerase. Thermostability was maintained with optimal RT occurring 
~70°C and consequently RTX was capable of single enzyme RT-PCR (in which RTX 
performs both the first-strand RT synthesis and PCR amplification). Across several RNA 
samples and gene loci, RTX demonstrated remarkable processivity on RNA templates, 
performing RT-PCR on RNAs over 5 kilobases in length (Fig. 3.5).  
RTX is a Proofreads on RNA and DNA Templates 
 We next tested if RTX retained the proofreading activities of the parental 
polymerase. Initial testing using dideoxy mismatch primers in PCR demonstrated robust 
proofreading activity on DNA template (Fig. 3.6), but it was unclear whether the 
proofreading mechanism was compatible during reverse transcription since RNA:DNA 
heteroduplexes can adopt A-form helical structures (Wang et al., 1982). Primer extension 
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with a canonical matched base pair or a 3' deoxy mismatched pair (preventing extension 
until terminator excision) were tested. As expected, both wild-type KOD and RTX were 
capable of extending mismatched primers on DNA templates, unlike exonuclease 
deficient mutants. When tested on a RNA template, KOD's exonuclease was stimulated - 
which actively degraded the priming oligonucleotide, while RTX could extend the 
mismatched primer with activity indistinguishable from DNA templated proofreading 
(Fig. 3.7).  
 Given RTX is the first polymerase capable of proofreading during reverse 
transcription, we hypothesized RTX may have increased RT fidelity compared to natural 
polymerases. Barcoded primers utilized during RT of several human mRNAs allowed 
multiple reads of a single cDNA during deep sequencing - reducing background 
sequencing errors by several orders of magnitude (Schmitt et al., 2012). Sequencing 
analyses revealed the control retroviral RT (MMLV) had an error rate between 4.8x10-4 
to 1.1x10-4 while RTX had an error rate of 3.5x10-5 to 3.7x10-5 (3 to 10 fold lower) (Fig. 
3.7). The mutational spectra of RTX favored G to A transitions and G to T transversions, 
which accounted for nearly half the observed mutations. Inactivating the RTX's 
proofreading capabilities increased error frequency nearly 3-fold, supporting active 
proofreading was occurring during RT. Interestingly, inactivating the proofreading of 
RTX shifted the mutational bias - perhaps due to preferential editing of particular 
mismatches (Fig. 3.7 and Table 3.2). Given the barcoding error detection limit is identical 
to the observed error of RTX (Schmitt et al., 2012) (confirmed by measuring fidelity of 
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wild-type KOD on DNA templates (Table 3.2)), we anticipate the true error rate for RTX 
to be even lower than reported. 
RTX in Nextgen RNAseq Workflows 
 Due to its unique properties, RTX has great potential to streamline workflow 
(combining RT and PCR steps) and increase the precision of transcriptomics, reducing 
biases and errors introduced in the reverse transcription step of RNA-Seq protocols 
(Ozsolak and Milos, 2011). To demonstrate the immediate utility, we implemented RTX 
into a commonly used platform for directional RNA sequencing. Analysis revealed nearly 
identical coverage and expression profiles, suggesting that RTX is compatible with 
established workflows. In addition, we developed a more streamlined protocol to directly 
sequence RNA. Using a traditional Sanger sequencing approach (Sanger et al., 1977), a 
GATC5 RNA repeat was directly sequenced (Fig. 3.8). Direct RNA sequencing should be 
adaptable to single molecule sequencing platforms, enabling high throughput and high 
fidelity sequencing of complex RNA samples by eliminating the biases created in cDNA 
synthesis and subsequent amplification. 
 Beyond applications in sequencing, the surprising flexibility of the RTX lineage 
may presage the ability to utilize entirely new chemistries in genetics. Primer extension 
reactions were performed on a ribose sugar analog (2' O-methyl DNA) that indicated that 
reverse transcription of RTX polymerases could extend alternative templates but with 
much lower efficiency, indicating a preference for RNA substrates (Fig. 3.9). However, 
RTX was still far more efficient at utilizing 2’-OMe DNA than the parental wild-type, 
 96 
opening the door to further optimization and due to 2'-OMe stability, potential therapeutic 
applications. 
DISCUSSION  
RTX as a Second Origin of Reverse Transcription  
 The directed evolution of RTX marks a second origin for RNA reverse 
transcriptase function  fundamentally distinct from the retroelement lineage. Using the 
RT-CSR process, the substrate specificity of a high fidelity DNA polymerase was 
fundamentally altered - highlighting the remarkable plasticity of highly conserved 
molecular machinery. Ostensibly, the mutations found unlocked molecular checkpoints in 
the discrimination of DNA and RNA, but surprisingly did not disrupt the proofreading 
capabilities of the polymerase. This was unexpected especially given RNA:DNA hybrid 
duplexes often form A-helical structures unlike DNA:DNA duplexes, and may provide 
insights into the transition from polymerization to editing modes of the polymerase. We 
found that reverse transcription proofreading increased the fidelity of cDNA synthesis 
above those found in natural retroviral RTs, which enabled higher precision RNA-Seq.  
RTX and the Implications for the Origin of Life and Future Reverse Transcription 
 Only a handful of mutations were required to impart RT activity, suggesting the 
evolutionary hurdle for high fidelity reverse transcription is relatively low. Despite this, 
all retroelements utilize proofreading deficient RTs suggesting that high error rates are 
either a historical coincidence or an evolutionary strategy to promote diversity. Another 
possible explanation is that high fidelity was never required simply because RNA 
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genomes are small due to their inherent instability (Huff et al., 1964). Given the plasticity 
of these polymerases for modified templates and the adaptability of the RT-CSR 
framework (as primers are simply programmed to contain modified bases), RTX 
evolution should be compatible with many base and sugar analogs (Malyshev et al., 
2012; Schoning, 2000; Yamashige et al., 2012; Yang et al., 2011). Combination with 
already evolved XNA polymerases could enable synthesis of genomes entirely composed 
of artificial nucleic acids (Pinheiro et al., 2012). Further integration with other synthetic 
machinery such as expanded genetic codes or engineered ribosomes will begin to further 
increase the gap between synthetic and natural life. 
MATERIALS AND METHODS 
Initial reverse transcription test for polymerases 
 30 pmol of 5' fluorescein labeled primer (25FAM) were annealed with 30 pmol of 
template and 0.4 µg of polymerase by heat denaturation at 90°C for 1 minute and 
allowing to cool to room temperature. Reactions were initiated by the addition of "start" 
mix which contained (50 mM Tris-HCl (pH8.4), 10 mM (NH4)2SO4, 10 mM KCl, 2 mM 
MgSO4) and 200 µM dNTPs. MMLV polymerase was treated according to manufacturers 
recommendations (New England Biolabs). Reactions were incubated for 2 minutes at 
68°C until terminated by the addition of EDTA to a final concentration of 25 mM. The 
labeled primer was removed from the template strand by heating sample at 75°C for 5 
minutes in 1x dye (47.5% formamide, 0.01% SDS) and 1 nmol of unlabeled BLOCKER 
oligonucleotide (to competitively bind the template strand). Samples were run on a 20% 
(7 M urea) acrylamide gel.  
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Reverse Transcription CSR (RT-CSR) 
 KOD polymerase libraries were created through error prone PCR (unless 
otherwise indicated) to have a mutation rate of ~1-2 amino acid mutations per gene. 
Libraries were cloned into tetracycline inducible  vector and electroporated into DH10B 
E. coli. Library sizes were maintained with a transformation efficiency of at least 106, but 
more typically 107-108. Overnight library cultures were seeded at a 1:20 ratio into fresh 
2xYT media supplemented with 100 µg / mL ampicillin and grown for 1 hour at 37°C. 
Cells were subsequently induced by the addition of anhydrotetracycline (typically at a 
final concentration of 200 ng / mL) and incubated at 37°C for 4 hours. Induced cells (200 
µL total) were spun in a tabletop centrifuge at 3,000 x g for 8 minutes. The supernatant 
was discarded and the cell pellet was resuspended in RTCSR mix: 1x Selection buffer (50 
mM Tris-HCl (pH8.4), 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4), 260 µM dNTPs, 
530 nM forward and reverse RNA containing primers. The resuspended cells were placed 
into a 2 mL tube with a 1mL rubber syringe plunger and 600 µL of oil mix (73% 
Tegosoft DEC, 7% AbilWE09 (Evonik), and 20% mineral oil (Sigma-Aldrich)). The 
emulsion was created by placing the cell and oil mix on a TissueLyser LT (Qiagen) with 
a program of 42Hz for 4 minutes. The emulsified cells were thermal-cycled with the 
program: 95°C - 3min, 20x (95°C- 30 sec, 62°C- 30 sec, 68°C- 2 min). Emulsions were 
broken by spinning the reaction (10,000 x g - 5 min), removing the top oil phase, adding 
150 µL of H2O and 750 µL chloroform, vortexing vigorously, and finally phase 
separating in a phase lock tube (5Prime). The aqueous phase was cleaned using a PCR 
purification column which results in purified DNA, including PCR products as well as 
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plasmid DNA. Subamplification with corresponding outnested recovery primers ensures 
that only polymerases that reverse transcribed are PCR amplified. Typically this is 
achieved by addition of 1/10 the total purified emulsion using Accuprime Pfx 
(ThermoFisher) in a 20 cycle PCR, however challenging rounds of selection could 
require increasing the input DNA or cycle number to achieve desired amplification.   
Molecular Modeling of RT-CSR Mutations 
 The wild-type structures of the family B polymerases from Thermococcus 
kodakaraensis (KOD) (PDB: 4K8Z) and Thermococcus gorgonarius (PDB: 2VWJ) were 
prepared for mutational analyses using the Molecular Operating Environment 
(MOE.10.2015) software package from Chemical Computing Group. The structures were 
inspected for anomalies and protonated/charged with the Protonate3D subroutine (341K, 
pH 8.0, 0.1 M salt). The protonated structures were then lightly tethered to reduce 
significant deviation from the empirically determined coordinates and minimized using 
the Amber12:EHT forcefield with Born solvation model to an RMS gradient of 0.1 kcal 
mol-1 Å-1.  These structures were then used as templates to build homology models of 
RT-CSR mutations.  Homology models of the variants were prepared by creating 25 main 
chain models with 25 sidechain samples at 341K (625 total) within MOE. Intermediates 
were refined to an RMS gradient of 1 kcal mol-1 Å-1, scored with the GB/VI 
methodology, minimized again to an RMS gradient of 0.5 kcal mol-1 Å-1, and protonated. 
The final model for each variant was further refined by placing the protein within a 6 Å 
water sphere and minimizing the solvent enclosed structure to an RMS gradient of 0.001 
kcal mol-1 Å-1.  Models were evaluated by calculating Phi-Psi angles and superimposed 
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against the reference structures. RNA:DNA A-form duplexes were created and 
superimposed against the empirically derived coordinates for the DNA:DNA duplex. 
Models were then minimized and contact energies measured within MOE. 
Cloning and purification of polymerase variants  
 Escherichia coli DH10B and BL21 (DE3) strains were used for cloning and 
expression, respectively. Strains were maintained on either Superior or 2XYT growth 
media. Polymerases were cloned into a modified pET21 vector using NdeI and BamHI 
sites. Overnight cultures of BL21 (DE3) harboring each of the variants were grown 
overnight in Superior broth at 37°C. Cells were then diluted 1:250, and protein 
production was induced with 1 mM IPTG during mid-log at 18°C for 20 hrs. Harvested 
cells were flash-frozen and lysed by sonication in 10 mM phosphate, 100 mM NaCl, 0.1 
mM EDTA, 1 mM DTT, 10% glycerol, pH 7 (Buffer A). Cleared cell lysates were heated 
at 85˚C for 25 min, cooled on ice for 20 minutes, and filtered (0.2 μm). The filtrate was 
then passed over a DEAE column, immediately applied to an equilibrated heparin 
column, and eluted along a sodium chloride gradient. Polymerase fractions were 
collected and dialyzed into Buffer A. Enzymes were further purified using an SP column 
and again eluted along a salt gradient. Pooled fractions were then applied to a Sephadex 
16/60 size exclusion column (GE Healthcare), concentrated, and dialyzed into storage 
buffer (50 mM Tris-HCl, 50 mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.1% Non-idet P40, 
0.1% Tween20, 50% glycerol, pH 8.0). Working stocks were made at 0.2 mg/mL. 
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PCR Proofreading Assay 
 50 µL PCR reactions were set up with a final concentration of 1x Assay Buffer 
(60 mM Tris-HCl (pH8.4), 25 mM (NH4)2SO4, 10 mM KCl), 200 µM dNTPs, 2 mM 
MgSO4, 400 nM or forward and reverse primers, 20 ng of template plasmid and 0.2 µg 
polymerase. Reactions were thermal-cycled using the following program: 95°C - 1min, 
25x (95°C- 30 sec, 55°C- 30 sec, 68°C- 2 min 30 sec).  
Primer Extension Assay 
 10 pmol of 5' fluorescein labeled primer were annealed with 50 pmol of template 
RNA or DNA and 0.4 µg of polymerase by heat denaturation at 80°C for 1 minute and 
allowing to cool to room temperature. Reactions were initiated by the addition of "start" 
mix which contained (1x Assay Buffer, 2 mM MgSO4 and 200 µM dNTPs. Reactions 
were incubated for 10 minutes at 68°C until terminated by the addition of EDTA to a 
final concentration of 25 mM. The labeled primer was removed from the template strand 
by heating sample at 75°C for 5 minutes in 1x dye (47.5% formamide, 0.01% SDS) and 1 
nmol of unlabeled blocker oligonucleotide (to competitively bind the template strand). 
Samples were run on a 20% (7 M urea) acrylamide gel.  
Reverse transcriptase fidelity (SSCS) 
 Templates for SSCS were prepared by first strand reverse transcription or primer 
extension (plasmid DNA template) with barcoded primer. Polymerization reactions were 
carried out according to manufacturer's recommendations for recombinant MMLV (New 
England Biolabs). For experimental polymerases, reverse transcription or primer 
extension was performed in 1x Assay Buffer, 200 µM dNTPs, 1 mM MgSO4, 400 nM 
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barcoded reverse primer, 40 units RNasin Plus,  0.2 µg polymerase, and template (1 µg 
Human heart total RNA or 1 ng plasmid). Reactions were incubated at 68°C for 30 
minutes (cDNA synthesis) or 2 minutes for DNA primer extension. Single stranded 
products were PCR amplified using Accuprime Pfx polymerase (ThermoFisher) with 
reverse and corresponding indexed forward primer. Samples were submitted for Illumina 
miseq PE 2x250.  
 Targeted DNA sequencing reads were aligned and grouped based on unique 
molecular barcodes tagging individual reverse transcription events using ustacks (v1.35). 
Using a modified version of the single strand consensus sequence program (SSCS), only 
groups containing three or more reads were analyzed. From these reads, a consensus 
sequence was built if more than sixty-six percent of the bases at each position were in 
agreement, otherwise the base was called as N and disregarded in the remaining analysis. 
Consensus reads were then aligned to the reference sequence using BWA-MEM (v0.7.7), 
and single nucleotide variants and indels were identified. The polymerase fidelity was 
calculated as the sum of indels and erroneous bases as a fraction of the total number of 
aligned bases.  
RTPCR Assay 
 50 µL reverse transcription PCR (RTPCR) reactions were set up on ice with the 
following reaction conditions: 1x Assay Buffer, 1 mM MgSO4, 1 M Betaine (Sigma-
Aldrich), 200 µM dNTPs, 400 nM reverse primer, 400 nM forward primer, 40 units 
RNasin Plus (Promega), 0.2 µg polymerase and 1 µg of Total RNA from Jurkat, Human 
Spleen or E. coli (Ambion). Reactions were thermal-cycled according to the following 
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parameters: 68°C - 30 min, 25x (95°C- 30 sec, 68°C (63°C for rpoC) - 30 sec, 68°C - 30 
s/kb). 
Single nucleotide incorporation kinetics 
 Duplexes (DNA:DNA or DNA:RNA) were assembled by combining equimolar 
amounts of a DNA 25-mer (5’-CCCTCGCAGCCGTCCAACCAACTCA-3’) and DNA 
or RNA 36-mer (3’-GGGAGCGTCGGCAGGTTGGTTGAGTGCCTCTTGTTT-5’) in 
10 mM Tris-HCl, 0.1 mM EDTA (pH 8.0). Solutions were heated to 95°C for 5 min, 
slowly cooled to 60°C for 10 min, and then cooled to room temperature for 15 minutes. 
Reactions (100 μL) consisting of assay buffer, 1 mM MgSO4, and 500 nM duplex were 
initiated by variable amounts of α-P32-dCTP (0.003-400μM), which was diluted 1:400 in 
unlabeled dCTP. Reactions were allowed to proceed 3-14 minutes. 10 μL aliquots were 
quenched by the addition of EDTA (0.25 M final concentration) in 15-120s intervals. 
Aliquots (2 μL) were spotted on DE81 filter paper and washed 6 times in 5% NaH2PO4 
(pH 7), 2 times in ddH2O and finally in 95% EtOH. Dried filter paper was exposed for 24 
hrs and imaged on a STORM scanner. Initial rates were obtained by analysis using FiJi 
(Image J). Kinetic parameters were determined by non-linear regression using 
SigmaPlot10. 
RNA sequencing and analysis 
 RNA from U87MG glioblastoma cells (ATCC® HTB-14) were harvested using 
trizol LS following manufacturer’s instructions (10296-028, Thermo fisher scientific). 
Ribosomal RNAs were then removed from the RNA samples using Ribozero rRNA 
removal kit (MRZH11124, Epicentre) and cleaned using RNeasy MinElute Cleanup Kit 
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(Qiagen). rRNA depleted RNAs were fragmented using NEBNext Magnesium RNA 
Fragmentation Module (E6150S, NEB) to 200-300bp size range followed by kinase 
treatment  to prepare for adaptor ligation. Illumina libraries were prepared using 
NEBNext Multiplex Small RNA Library Prep kit (E7580, NEB) and size selected to 
remove adaptor dimers using Ampure XP beads. 6 Illumina libraries were prepared from 
the same pool of RNA using experimental reverse transcriptases and ProtoScript II 
Reverse Transcriptase from the library prep kit.  RNASeq libraries were sequenced on 
Illumina HiSeq 2000, 2x100bp by the genome sequencing and analysis facility at the 
University of Texas at Austin.  
 The evaluation of RNA-seq quality control metrics was performed via RNA-
SeQC (v1.1.8). For transcript abundance analysis, fpkm values were generated through 
the cufflinks/cuffnorm pipeline (v2.2.1) and transformed both by log2 and to fit the range 
[-3,3].  
RNA Sanger Sequencing 
 Sanger sequencing reactions were set up by preparing 1X Assay Buffer, 1 mM 
MgSO4, 10 pmol RT.Probe, 50 pmol SangerGATC Template, 0.4 ug RTXexo- , and 50 
µM dNTPs. For the indicated terminator nucleotide, a 25:1 ratio of 3' dideoxy terminator 
to unmodified NTP was used. Reactions were thermal cycled 6x (68°C - 20sec, 85°C - 
5sec). Reactions were terminated by the addition of EDTA to a final concentration of 25 
mM. The labeled primer was removed by heating sample at 75°C for 5 minutes in 1x dye 
(47.5% formamide, 0.01% SDS) and 1 nmol of unlabeled SangerBlocker oligonucleotide. 
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Figure 3.1 : Evolution of a synthetic family of reverse transcriptases by RT-CSR  
a, Polymerase phylogeny depicts reverse transcription xenopolymerases (RTX) as a 
second, evolutionarily distinct, origin of reverse transcriptase. Unlike native reverse 
transcriptases, Archaeal family-B polymerases are proofreading - allowing RTX the 
potential for proofreading reverse transcription. b, Framework for the directed evolution 
of hyper-thermostable reverse transcriptase using reverse transcription 
compartmentalized self replication (RT-CSR). Libraries of polymerase variants are 
created, expressed in E. coli, and in vitro compartmentalized. During emulsion PCR, 
primers flanking the polymerase enable self-replication, but are designed with a variable 
number of RNA bases separating the plasmid annealing portion from the unique recovery 
tag. Outnested PCR ensures that only polymerases with reverse transcriptase activity are 




Figure 3.2 : Characterization of the B11 Polymerase 
a, Mutations in the B11 polymerase (yellow) are mapped onto the KOD polymerase (grey 
with DNA primer:template duplex in blue). Thirty seven mutations were accumulated, 
many found in the proofreading domain. b, Examination of the 3'-5' exonuclease active 
site shows a mutation at glutamate 143 to glycine. c, Functional assays reveal B11 
polymerase is capable of single enzyme RTPCR of a 500 base pair region of the HSPCB 
gene, as well as the B11 with grafted wildtype proofreading domain. Proofreading 
activity was qualitatively measured in a dideoxy-mismatch PCR, which requires removal 
of a 3' deoxy mismatch primer before polymerization occurs. d, Kinetics of KOD 
polymerase (D141A, E143A) and B11 polymerase on DNA and RNA templates. 
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Table 3.1 : Mutations of KOD Polymerase Throughout RT-CSR 
Deep sequencing of RT-CSR libraries. Amino acid residues with mutations occuring in 
10% of the population are shown in order of frequency. Some positions contained several 
amino acid possibilities and the sum of frequencies were totaled. Synonymous mutations 






Figure 3.3 : Molecular checkpoints involved in the transition of template recognition  
a, Structural heat map of mutated residues over the RT-CSR process found by deep 
sequencing. Conserved mutations are colored incrementally darker shades of red to 
indicate frequency in the polymerase pool. Amino acid residues that were mutated in over 
50% of the population were labeled. Figure was adapted from KOD structure PDB 4K8Z. 
b, Computer modeling of KOD (grey) and RTX mutations (orange) at checkpoints 
responsible for DNA and RNA template recognition at R97, Y384, and E664. Free 






Figure 3.4 : Kinetic Characterization of Polymerases 
Steady-state kinetics of polymerase variants. Initial rates of single nucleotide (dCTP) 
incorporation by exonuclease deficient polymerases were plotted against the 
concentration of dCTP using DNA (a) or RNA templates (b). c, Kinetic parameters were 
estimated by fitting the data to the Michaelis-Menten equation. Nucleotide addition could 































Figure 3.5 : RTPCR Reactions with RTX Polymerase 
Reverse transcription PCR (RTPCR) was performed using KOD polymerase, RTX, and 
the proofreading deficient version of RTX (N210D; exo-). Various genes were amplified 
(red), two human genes, PolR2A and p532, and rpoC from E. coli from various RNA 
sources. Using gene specific forward and reverse primers, gene regions were amplified, 




Figure 3.6 : RTX Polymerase Proofreads on a DNA Template 
DNA polymerase activity was assessed by PCR using unmodified primers on a 2.5 
kilobase fragment. Proofreading (3'-5' exonuclease activity) was assessed by use of 3' 
deoxy mismatch primers in the PCR. Inactivating the proofreading domain (N210D) in 






Figure 3.7 : RTX polymerase proofreads during reverse transcription  
a, Primer extension reactions of KOD and RTX polymerases and their proofreading 
deficient counterparts (exo-), on both DNA and RNA templates. Extension reactions 
were performed with matched 3' primer:templates (grey) or a 3' deoxy mismatch 
(orange), which must be excised before extension can proceed. The primer is denoted by 
a gray arrow, extended product in green, and exonuclease degraded primer in red. b, 
Deep sequencing of reverse transcription reaction on HSPCB gene. The overall error rate 
was determined by dividing the sum of base substitutions and indel formation by the total 
number of bases sequenced. The error profile of MMLV, RTX, and RTX exo- is shown 





Table 3.2 : Fidelity of RTX Polymerases on DNA and RNA Templates  
a, Fidelity profile for reverse transcription on two human genes, HSPCB and PolR2A 
using the SSCS technique. The error rate is calculated by dividing total mutations 
(mismatch + indel) over the total number of bases sequenced. The frequency of each 
possible mutation is listed as a percentage of total mutations. b, Fidelity profile for DNA 




Figure 3.8 : Direct Sanger Sequencing of RNA Templates 
Primer extension reactions were carried out with a 5' FAM labeled oligonucleotide with 
terminator nucleotides (ddGTP, ddATP, ddTTP, ddCTP) at a 25:1 ratio (ddXTP:dXTP). 
Reactions were performed with RTX exo- to prevent exonuclease cleavage of terminated 
extension products. The primer:template RNA complex is depicted with the 3' hydroxyl 


















Figure 3.9 : RTX polymerizes across 2' O-methyl DNA Templates 
Primer extension reactions on DNA and 2' O-methyl DNA substrates using KOD, KOD 
exo-, RTX, and RTX exo-. KOD polymerases were not capable of primer extension 
indicating 2' O-methyl DNA is not a substrate. RTX enzymes could polymerize across 2' 




 The works herein describe the means in which to engineer various aspects of the 
central dogma of biology. The main role emulsion based technology has played should 
not be underestimated, as the separation of reactions into individual microreactions 
allows the selection of large libraries of functional proteins or nucleic acids. This was 
specifically achieved because genotype-phenotype linkage could be maintained, as well 
as, the ability to introduce non-native substrates into the emulsion droplets. Using these 
basic engineering principles several novel systems were developed that enabled the in 
vitro selection of tRNAs, tRNA-synthetases, T7 RNA polymerase, allosteric repressors 
for a wide range of function, and the creation of the first proofreading reverse 
transcriptase. In this section, lessons from the selections are discussed that are not simply 
anecdotal, but are principles that are likely to be true across a wide range of selections for 
different molecules, especially using the approaches developed here. A discussion about 
future selections and methods will also be included as perhaps a jumping point for future 
ideas. 
AN UNEXPECTED JOURNEY 
 In our initial projects in graduate school, Adam Meyer and I had been working on 
an evolution scheme using an in vitro autogene system where a T7 RNA polymerase 
would copy its own gene, by placing its promoter sequence upstream of the T7 coding 
sequence (Davidson et al., 2012). This scheme is elegant in its simplicity, which is why it 
was such an attractive approach as an engineering platform. In the end, this system was 
not robust enough to allow even the evolution of itself and certainly not in more complex 
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pathways. After several cycles of selection, the autogene would error catastrophe and be 
overtaken by molecular parasites that arise during the reverse transcription and PCR 
recovery of the RNA. Whilst we could speculate in depth about why this system was not 
evolutionarily stable, the highest level justification was that the selective advantage of the 
most active polymerases was lost. This could be for many reasons: perhaps each 
compartment only contained enough resources to make a single protein copy of the T7 
gene, perhaps there were not enough RNA nucleotides to allow the self-amplification in 
any meaningful way, or maybe the nuclease that is often used to treat lysates had residual 
activity and degraded what little RNA came out of the system in the first place (Pelham 
and Jackson, 1976). Whatever the problem was, the system would collapse after several 
cycles of selection and become useless for self evolution, and the fact that it could not 
even evolve self meant that trying to make the system more complex would be a fruitless 
endeavor.  
 Despite the failures of the autogene, it was a proving ground for directed 
evolution chops and theories. The autogene was a black box and it was hard to peek 
inside to try and diagnose issues. The rabbit reticulocyte lysate was provided from a 
commercial source and therefore the treatment procedures were largely unknown and the 
consequences not understood (Davidson et al., 2012; Ghadessy and Holliger, 2004). 
Lysates in general only have a limited capacity for transcription and protein production. 
Unlike a living system, a lysate cannot respond to signals and produce more protein or 
recycle metabolites. The buildup and accumulation of expended metabolites will inhibit 
the transcription and translation capacity (Carlson et al., 2012). In addition, it is 
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conceivable that the procedures involved in the breaking of the emulsion bubbles could 
introduce RNase which would degrade what little products the autogene made. But 
despite all the concerns and unknowns, in the end every piece of the autogene puzzle was 
optimized to allow even the slightest amount of evolution to occur. The techniques used 
to emulsify transcription/translation reactions could be used for other schemes down the 
road. Troubleshooting reverse transcription and PCR reactions was also a formative 
experience. In the end, the autogene was a trial by fire and clued me in on what would the 
most desirable features be in a directed evolution platform.  
 What are the features of a powerful directed evolution platform? There are several 
features which would distinguish itself from the problems faced by the autogene and 
many other popular directed evolution platforms (Glasscock et al., 2016; Packer and Liu, 
2015). The technique should be modular and adaptable. Selections that are specific to the 
evolution of a single component are limited, and would likely not be a platform 
technology which could be applied to a wide variety of situations. Also, the platform 
should give a large selective advantage to the library variants which are the most 
functional for the desired property. The most functional biomolecule gene variants should 
undergo a large enrichment in a single cycle of selection. Such that, if 1 in 500 molecules 
were active (vs. inactive) then following a single round the functional variant would 
come to the fore. The selective advantage should also be tunable, such that over the 
course of evolution the selective pressure can be adjusted. This is sometimes necessary as 
the desired function cannot be mutationally reached with a single point mutation, and the 
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biomolecule must be gently guided by modulating the stringency over time - allowing the 
accumulation of beneficial mutations.  
 The selection should be able to sample large library sizes, unlike a traditional 
screen where point mutations are tested individually or in a multiwall plate format. 
Oftentimes, an entire active site of a protein or RNA will need to be completely 
randomized (driven mostly by the fact that we have no real way of understanding the 
active site, or modeling one). Even the randomization of five amino acids of a protein 
will result in a large library (~3x107), if amino acids are fully randomized to allow every 
possible combination of the twenty amino acids. Sifting through a large sequence space 
of possibilities is often driven out of necessity. The selection should facilitate 
troubleshooting, unlike the issues faced previously with the autogene. Being able to 
examine the background biology using fairly standard techniques, such as checking 
expression levels from a promoter with a fluorescent protein, is oftentimes required to 
hone in on a set of conditions that facilitates in vitro selection. A sometimes overlooked, 
but logistically important, issue is how time consuming and practical the selection 
process is. In my experience, certain in vitro selections can take many cycles to generate 
the desired function. A complex phenotype may require iteration of the directed evolution 
cycle dozens of rounds (Johnston et al., 2001). Turning the evolutionary crank takes trial 
and error, and being motivated to turn that crank is where simplicity is important. 
Fortunately, I stumbled upon a system which meets these criteria.  
 The conception of compartmentalized partnered replication (CPR) was 
inadvertent. Collaborations with Michael Hammerling and Jeffrey Barrick about the 
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evolutionary implications of an expanded genetic code left me thinking about systems in 
which I could explore this question (Hammerling et al., 2014). Initially, we had been 
pushing forward the notion of evolution of entire organisms with an expanded genetic 
code, but this posed some large hurdles. When studying whole genomes, it is often hard 
to know the effect of individual mutations that occurred, unless they have previously 
been characterized. This is expounded by the fact that genomic evolution studies can 
generate a pile of data. When evolving phages, this was certainly the case. Without huge 
efforts to biochemically characterize the effect of nonstandard amino acids (NAAs) that 
appeared across the proteome, we essentially had no idea what they were doing on a 
structural and functional basis. For instance, two highly conserved amber codons (by 
proxy the unnatural amino acid 3-Iodotyrosine) appeared in the phage lysis protein, holin, 
and one in the T7 RNA polymerase gene. It is clear based on the very high enrichment 
during evolution that the NAAs in these proteins was giving the phage a selective 
advantage, perhaps due to increased function of the protein, but how? Because of the 
complexities studying organisms with expanded genetic codes, I wanted to focus on what 
impact NAAS would have at the individual protein level.  Using a model directed 
evolution system that utilized a well studied protein would enable me to probe this 
question. Are there generalizable functionalities that a specific NAA could impart on 
proteins? For instance, a NAA could possibly promote better folding of a polypeptide (for 
instance if it was highly charged (Lawrence et al., 2007)), or could enhance the active site 
of a conserved protease, or increase the thermal-stability of a protein (which was later 
demonstrated (Ohtake et al., 2015)). There needed to be a general platform for studying 
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this question. As I was exploring the options for which platform might lend itself to this 
problem, I inadvertently drew the first diagram of CPR . 
 CPR was born from the brilliant directed evolution scheme, compartmentalized 
self replication (CSR) that was developed by Philipp Holliger (Ghadessy et al., 2001). 
Exploring all turnkey directed evolution schemes that were available led to drawing the 
CSR scheme (polymerase evolution) with the NAA machinery (Fig. C.1). While this was 
initially intended to be a platform for the evolution of the polymerase, it was immediately 
obvious that this could also be a directed evolution platform for the NAA machinery, and 
more generally, anything that could influence the expression of Taq polymerase (or any 
PCR polymerase). For instance, we could go back and evolve T7 RNA polymerase which 
had previously failed with the autogene selection by simply driving the expression of the 
Taq polymerase with the T7 promoter. In order to select for different genes, primers 
could simply be reprogrammed to not flank the polymerase gene (like in CSR), but flank 
whatever gene or gene circuit was influencing the expression of the polymerase.  
 Another important distinction exists between CSR and CPR. In the CSR setup, 
each polymerase library variant (or cell) produces an equal amount of polymerase, and 
the differential replication of variants is driven by the functionality of the polymerase in 
the given selection parameters. In contrast, the selective advantage of library variants in 
CPR is driven entirely by the differential expression of the polymerase, such that there is 
a spectrum of Taq expression levels between variants. Based on how PCR works, it 
would stand to reason that the more polymerase that was present in a cell should greatly 
influence the efficiency of replication. This basic principle was demonstrated in the 
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manuscript (Ellefson et al., 2014); however there is an interesting caveat where each 
compartment has a finite amount of resources (for instance primers or dNTPs). If 
overcycled, compartments with less polymerase can catch up to compartments with more 
simply because resources were expended more quickly in the compartment with more 
polymerase. However, this issue is easily overcome by not overcycling the reactions 
during CPR.  
CPR ADVANTAGES OVER EXISTING DIRECTED EVOLUTION TECHNOLOGIES 
 Fortuitously, CPR has a number of advantages over preexisting directed evolution 
technologies – making it a strong contender as a platform technology for the directed 
evolution of a wide range of biomolecules (Packer and Liu, 2015). This is largely due to 
the unique combination of the selection being a combined in vivo and in vitro approach, 
with the biological circuit functioning during cell growth and the partnered replication 
happening inside of the emulsion bubble. Most existing methods for directed evolution of 
a wide array of functions (for instance based on gene expression) can be generalized to 
several categories with severe flaws. A classic example is the tying of gene function to 
expression of an antibiotic resistance marker. Gene libraries are cloned such that when 
functional will express a resistance gene and allow a given cell to survive and develop a 
colony on a plate or growth in liquid media. While in theory these selections should work 
marvelously, and have worked for the evolution of many biomolecules (Porcar, 2010), 
they are extremely prone to cheat. Since such a strong selective pressure (survival) is 
used, a cell will capitalize by any means necessary in order to survive. For instance, low 
levels of cloning artifacts while preparing the library or recombination during growth can 
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allow a cell to survive in such a way that it is not influenced by the desired gene. 
Oftentimes these artifacts will actually have a growth advantage over even a functional 
member, because they may more directly make the resistance gene or do not need to 
express the protein of interest which can sometimes be toxic.  
 A continuum of selective advantage is available during CPR. Gene or circuit 
function is directly associated with the in vivo production of more and more Taq 
polymerase, which subsequently will more effectively PCR amplify itself in the 
subsequent step. This is in contrast to a technique such as fluorescence based cell sorting 
(FACS), where sorting gates are used. While multiple gates can be set up, there is a clear 
line of being good enough. Antibiotic selections can have the same disadvantages, as 
oftentimes the dynamic range can be quite limited as long as the cell can produce enough 
of the resistance gene; it will survive a wide range of antibiotic concentration in the 
media.  
 Unlike most selection schemes, a large sequence space can be covered with 
relative ease. A single emulsion reaction will simultaneously select roughly 109 cells 
during the time frame of a single PCR reaction, without any additional manipulation. The 
bottleneck for library size is the E. coli transformation efficiency, which can typically 
allow up to 108 unique transformation events. While an antibiotic selection should be able 
to cover the same library size, the physical plating of the cells can be tricky such that 
single colonies can be isolated or to not allow growth of cells on top of a lawn of dead 
cells. While groups have reported FACS selection of libraries this size, this is clearly a 
monumental effort that cannot be routinely performed. Oftentimes to achieve optimal 
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sorting efficiencies, the number of events over time must be lowered, as faster sorting is 
often associated with accidental non-active cells being sorted. Even at its best, sorting is 
typically capped at ~106 events per hour which means that sorting a library of 107 would 
take ten hours. This is problematic not just as a time constraint, but cells awaiting sorting 
will often sit in a saline buffer solution which can have unknown consequences.  
 CPR is conducted in discrete non-continuous cycles. While this may limit the 
continuous march through sequence space, the limiting of selection parasites is of utmost 
importance. For instance, the most publicized continuous evolution scheme, phage 
assisted continuous evolution (PACE) (Esvelt et al., 2011), is prone to parasitic 
contamination (personal communication). The system uses M13 bacteriophage which 
harbors a gene that will influence the expression of an essential coat protein (G3P), which 
is located on an E. coli plasmid. A “lagoon” is set up in which fresh E. coli cells are 
pumped in and expended cells and M13 virus are sloughed off. This allows genes in the 
M13 to optimize over time, by iterative replication and mutations, to influence the 
expression of the G3P. However, the most common solution the phage will find towards 
increased production of G3P is to overexpress the gene influencing it. This is oftentimes 
the easiest way to improve function (is to simply have more of it), but does not result in 
proteins of increased function. The discontinuous nature of CPR allows the genes to be 
re-cloned into fresh plasmids, such that promoter strength and genetic context is the same 
between rounds. In addition, certain functionalities cannot be obtained by single point 
mutations (which is how phage explore sequence space) and require multiple mutations 
to happen simultaneously (Romero and Arnold, 2009). 
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FUTURE DIRECTIONS OF CPR BASED EVOLUTION 
 CPR relies on the differential expression of thermostable DNA polymerase, based 
on the functionality of a genetic part or circuit. There are many ways to directly tie the 
expression of Taq to certain cellular processes, as we have demonstrated for both 
transcription and translation. However, there are many enzymatic or protein functions 
that cannot directly be tied to gene expression. For instance, metabolic pathways that 
produce small molecules may not have a visible phenotype or affect cell growth. 
Metabolic engineering efforts, to produce valuable products using engineered organisms 
such as artemisinin (Paddon and Keasling, 2014), are often a great challenge because no 
visible phenotype is assocated with the small molecule of interest. However, life has 
found ways to alter gene expression based on the presence of small molecules by 
evolving regulatory genes that will specifically respond to them. For instance, E. coli 
regulates internal metabolites by placing genes into an operon structure which is often 
regulated by multiple components (McAdams et al., 2004). A common method for 
regulation is by an allosteric transcription factor, which conformationally responds to the 
small molecule of interest and regulates the pathway accordingly. By hijacking and 
rewiring allosteric transcription factors, gene expression can be influenced by the 
production (or degradation) of small molecules – allowing CPR to be used (Fig. C.2). 
Due to how allosteric transcription factors function, a dose-response curve is associated 
which can alter gene expression to varying degrees based on the concentration of the 
small molecule effector inside the cell. The dose-response of certain molecules can vary 
widely, ranging from a digital type response (“all or nothing”) or a graded response 
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(“analog” response). The difference in response is largely transcription factor dependent, 
and can be influenced heavily by factors such as cooperative binding (Giorgetti et al., 
2010). The dose-response properties of biological circuits can be tuned heavily based on 
design principles of synthetic biology (Daniel et al., 2013). For instance, redesigning the 
ribosomal binding site, operator sites, or even negative feedback on itself can influence 
the allosteric transcription factor dope-response. These parameters are critical for tuning a 
CPR circuit, to promote the most gene expression from the most functional variants in a 
library.  
 Given that most biotechnology or industrially relevant small molecules do not 
have an allosteric transcription factor that can be found in nature, it is almost certain that 
one will have to be engineered from scratch. Fortunately, CPR can be utilized for this as 
well. As a proof of concept, the tryptophan repressor was chosen to gain insights on the 
evolution of allosteric transcription factors (discussed in Chapter 2). The tryptophan 
repressor (TrpR) was chosen because it is very well studied and structures exist, which 
heavily guide library design. Secondly, it was chosen because I had previously evolved 
an aminoacyl tRNA synthetase that can incorporate 5-hydroxy-L-tryptophan in response 
to amber codons. My main objective was to create a nonstandard amino acid operon that 
would biosynthetically produce, regulate, and incorporate an unnatural amino acid. 
However, this did not work quite as expected. The first goal of the evolution of the TrpR 
was to alter the binding pocket to allosterically respond to new small molecule ligands – 
as engineering allosteric binding pockets to a wide variety of small molecules would be 
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necessary if CPR is to be adapted for metabolic engineering. Changing the pocket proved 
more challenging than originally conceived.  
 The CPR selection circuit was set up around positive and negative selection 
cycles. Binding would be selected for in the positive round, and not binding would be 
selected for in the negative round. This is essential because allosteric transcrpiton factors 
can typically evolve to become non responsive to the small molecule target and become 
always active irrespective of the small molecule (termed super-aporepressors). By 
cycling between rounds of positive and negative selection, a dynamic transcription factor 
can be selected that will only respond when the desired small molecule is present. In 
total, over half a dozen small molecules were used for directed evolution of the binding 
pocket. However, various results were achieved. Amino acid residues in the binding 
pocket of tryptophan would become fixed throughout the course of evolution (suggesting 
honing in on the best combination of amino acids), but the response varied widely. Some 
small molecules (including 5-hydroxy-L-trypophan) would only cause a several fold 
change of promoter regulation even at high concentrations (~1 mM). In the end, two 
molecules worked well, 5 and 6-bromo-L-tryptophan, and could alter gene expression by 
up to 50-fold.  
 This poses a problem, especially if transcription factors are going to be a modular 
scaffold for evolution of recognition of a wide variety of small molecule targets. Instead, 
focus was put into driving the evolution of other functions of the allosteric regulator, such 
as altering the operator binding site to respond to new DNA sequences. In the end, fifteen 
unique repressors were evolved that responded to tryptophan, 5-bromo-tryotophan, or 6-
 128 
bromo-tryptophan across five orthogonal DNA operators. The ability to take a single 
regulatory protein and evolve so many functions was very interesting from an 
evolutionary standpoint. It shows the molecular plasticity of proteins in general, but 
especially the ability for regulatory proteins to respond to new signals and regulate novel 
operator sites. This reveals the potential for a simple regulatory protein to develop 
complex regulatory architectures. However, there is a limitation for stacking the 
molecular logic of the tryptophan repressor by the expression of multiple repressors in a 
single cell.  
 The tryptophan repressor folds into a homodimer prior to binding to tryptophan 
and before binding the operator site. The interface region (which dictates dimer folding) 
is shared among all the variants created by directed evolution. If multiple species of 
repressors were expressed in the cell at the same time, then repressors would randomly 
dimerize and each would have a non-defined logic (or logic interference). To overcome 
this problem, libraries were made of a region of the interface that is known to prevent 
proper folding of the dimer. New binding pairs were identified, and were found to have 
various levels of success. In addition to this approach, it also seemed feasible to 
covalently attach the C-terminal residues to the N-terminal of the next dimer, creating a 
fusion (or tethered) repressor protein. This should promote intramolecular folding with 
the second half of the dimer, instead of dimerization with another repressor, and allow the 
expression of multiple repressors each with unique logics without interference between 
repressors. Using this approach the tethered repressors displayed NAND based logic; 
only binding and repressing gene expression when both conditions were met. For 
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instance, if the 5-bromo variant was tethered to the 6-bromo variant then repression 
would only occur when both small molecules are present.  
 Despite the relative successes of engineering the tryptophan repressor, there were 
some severe limitations that would prevent this from being a platform for engineering 
more industrially relevant metabolic pathways. The initial attempts to change the 
allosteric effector specificity led to many failures, and exhaustive attempts were made at 
finding tryptophan analogs that would work. My fear, even before beginning work on the 
tryptophan repressor was that the binding pocket looked rigid. Based on how the dimer 
folds, there are many structurally important residues in or near the pocket, making major 
modifications a concern. In addition, the back wall of the pocket is an alpha helix, which 
limits the types of molecules that could possibly fit into the pocket. Some of the most 
adaptable binding pockets are generally less structured and play negligible roles in the 
folding of the protein (Dellus-Gur et al., 2013; Tóth-Petróczy and Tawfik, 2014). If 
designing the perfect platform transcription factor, one that could bind a wide array of 
small molecules, a different scaffold besides the TrpR would have to be used. This could 
be a more widely used scaffold such as the Lys-R type transcription factor family, which 
are the most broadly used regulatory family in prokaryotes. Perhaps a transcription factor 
could even be designed from scratch, by the fusion of a DNA binding domain to a highly 
engineerable binding pocket, like a single chain antibody. 
POLYMERASE EVOLUTION OF FUNCTION 
 Before beginning to lay the foundations of CPR, I attempted to amplify a portion 
of the Taq polymerase gene using CSR. The demonstration was beautiful - a single clear 
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PCR product was visible directly after the emulsified CSR reaction was broken. Although 
focused primarily on pushing CPR forward, the notion of polymerase engineering stuck 
with me. The first thought was to try and gene shuffle two very utilized family-B 
polymerases for high fidelity PCR reactions, the replicative polymerase from Pyrococcus 
furiousus (PFU) and Thermococcus kodakarensis (KOD). Both of these polymerases 
share a high degree of sequence homology (making gene shuffling feasible). Despite 
having nearly identical sequences, there are functional differences such as KOD having 
higher processivity or PFU being higher fidelity. In a CSR selection, libraries of gene 
shuffled variants could be parsed to find polymerases that may contain the best features 
of both polymerases. A rotation student, Daniel Garry (and later Thomas Wall), began 
this project and turned several rounds of CSR. Shuffled polymerase variants were 
screened and identified. These displayed promising characteristics, such as the ability to 
generate more PCR amplification (which CSR often enriches for). In fact, the Ellington 
lab as a whole still uses a variant of these polymerases, A12, which is useful mostly as an 
error prone polymerase. Although publications were not generated as a result of this 
work, it laid the groundwork for what would later be the evolution of the first 
proofreading reverse transcriptase. 
 Since CSR selections became a routine process in the lab, there was general 
curiosity if we could also engineer another DNA polymerase, the reverse transcriptase. 
However, there were some serious hurdles to using a CSR type evolution scheme with 
common reverse transcriptases such as MMLV. The CSR process uses high heat as an 
initial step to break open cells that contain the polymerase variants, which would heat 
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denature common retroviral RTs. Secondly, the primers used to flank the polymerase 
gene in CSR would have to be redesigned to specifically bind RNA, which in an 
organism like E. coli can be difficult because the DNA sequence is identical. Primers 
would indiscriminately bind the RNA or DNA and template, causing amplification even 
if reverse transcriptase activity was not present. Exponential amplification would also be 
impossible, again given the lack of thermostability that is required to drive a PCR 
reaction (plus after the first cycle of PCR, the RNA template would become irrelevant). It 
took years for these mental hurdles to be overcome.  
 To formulate the concepts behind the first proofreading reverse transcriptase, two 
ideas needed to come together. If primers were designed with RNA bases that would 
flank the polymerase in the CSR, then during the synthesis of the second strand the 
primer would serve as a template. Designing a unique capture sequence at the ends of the 
primer ensured that only polymerases that could reverse transcribe across the RNA 
challenge region would be amplified. This was a great solution for two main reasons, the 
polymerase would have to reverse transcribe every cycle of PCR (in contrast to reverse 
transcribing its own gene a single time) and the stringency of selection could be easily 
tuned by the stepwise addition of longer RNA stretches in the primer region. In fact, as 
more and more RNAs are added to the primer, eventually the entire sequence will be 
RNA - requiring efficient reverse transcription every cycle of PCR to maintain 
exponential amplification in the reaction. The second idea, was perhaps boldness or 
ignorance. A thermostable (capable of PCR) polymerase needed to be used in this 
pipeline. KOD polymerase was an obvious choice (it was my favorite polymerase) 
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because it is extremely processive and has a highly active proofreading domain. 
However, KOD polymerase does not have any initial reverse transcriptase activity, but I 
reasoned it could be evolved given the chemical differences in DNA and RNA templating 
should be quite small. I thought there must be amino acid residues that enforce strict 
DNA utilization and that these could be mutated to residues that would be accepting of 
RNA templates.  
 As rounds of selection, termed reverse transcription compartmentalized self 
replication (RT-CSR), were turned the notion that a polymerase like KOD could be a 
reverse transcriptase became less hypothetical. In subsequent cycles, the polymerases 
were able to survive on selective pressure where in previous rounds it was not – 
suggesting a gradual transition to reverse transcriptase activity. Sequencing of the 
variants in early rounds of RT-CSR showed two very prominent mutations, R97X (X = 
multiple possibilities) and N210D. The R97 mutation is certainly very intriguing, as it sits 
next to the uracil binding pocket. This pocket, in the native polymerase, scans the 
template for uracil residues which should never exist in template DNA unless cytosine 
deamination occurs, and stalls - giving time for repair machinery to correct the mistake. 
Interestingly, when the structure of this complex was resolved researchers made a 
mutation to V93Q (Fogg et al., 2002), which sits inside of the uracil binding pocket. The 
RT-CSR process (and actually normal CSR) consistently identified R97 as the key 
residue for inactivating this pocket, presumably due to disruption of an ionic bond to the 
backbone phosphate. Mutation of the uracil binding pocket makes perfect sense, as RNA 
is chock full of template uracils, but the intriguing part is that the selection process 
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identified a residue that presumably accomplishes what V93Q does, but better. This is 
interesting, and suggests that other mutations commonly used in the polymerase may not 
be optimal residues. For instance, the Y409G and A485L mutations are commonly used 
for incorporation of dNTP analog substrates, but may not be truly optimal since they 
were identified from small screens as a result of a crystal structure (Gardner and Jack, 
1999). The other position, N210D, has been shown previously to inactivate the 
proofreading domain of the polymerase (Nishioka et al., 2001). While initially it was 
thought that this mutation might be essential to the evolution of RT activity (thereby 
preventing a proofreading reverse transcriptase), other experiments confirm that this is a 
general phenomenon of CSR selection itself - as polymerases attempt to maximize their 
self replication (and inactivation of the proofreading domain is a simple strategy to 
achieve this).  
 Throughout the eighteen rounds of selection the polymerase accumulated many 
mutations. Each cycle of RT-CSR generally will require over 60 cycles of PCR for 
reamplification, recovery, and the self replication during the selection (which likely 
introduces the most mutations given the proofreading domain is mutated). By the final 
rounds of RT-CSR, polymerases contained roughly forty mutations. Many of these were 
simply due to the accumulation of neutral mutations given the heavy mutational load of 
the system, and sequence conservation and location served as guidelines for the 
mutations that were most important for RT activity. In addition, experiments where the 
wild-type 3’-5’ exonuclease domain was transplanted on the mutant RT suggested that 
proofreading could be restored by eliminating spurious mutations. By designing 
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polymerases that only contained the core set of mutations required for RT activity, the 
KOD based reverse transcriptase recovered its proofreading activity which was found to 
act both on RNA or DNA template. 
 Since this is the first demonstration of a proofreading reverse transcriptase, what 
were the effects on the fidelity of the RT reaction? The effect of the proofreading domain 
on DNA templated polymerization is well known to increase the fidelity of genome 
synthesis, but would this translate to reverse transcription? Most tools to measure the 
fidelity of polymerases are inherently flawed because they use methods relying on 
cloning of a genetic or phenotypic marker and count cells based on presence or absence 
of the trait screened/selected for. The basic equation for fidelity consists of the fraction of 
positive by the negative phenotypes with added assumptions including the number of 
doublings or the probability that a given mutation will destroy function of the gene. The 
inability to detect neutral mutations or cloning artifacts has had consequences in the 
consistency of data about polymerase fidelity from lab to lab, sometimes ranging several 
orders of magnitude (Moser et al., 2012; Takagi et al., 1997). Due to the traditional flaws 
of fidelity measurements and that they do not precisely measure the types of mutations, a 
new assay was developed. The assay is based around the idea of single stranded 
consensus sequencing (SSCS), which was modified slightly to contain unique barcodes in 
the reverse transcription primer. This allows a single reverse transcription event to have 
an appended barcode sequence which can be used during next-gen sequencing to negate 
errors that were not derived during the RT by creating a consensus sequence of all reads. 
While the SSCS method also has a limited threshold for error detection (~3x10-5) due to 
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error that occur during PCR amplification of the single stranded cDNA, it should give a 
more accurate and consistent account of the fidelity of a polymerase.  
 In addition, this relative fidelity approaches the error rate of transcription itself 
which without a further methodological advance will cap the possible error detection 
(regardless of using a genetic based marker or a sequencing approach). However, other 
research groups have developed clever methods for precisely measuring the fidelity of 
transcription (Gout et al., 2013; Traverse and Ochman, 2016). If these techniques were 
coupled with our approaches, it could enable exact error detection of polymerization. The 
ability to measure fidelity in a high throughput fashion would not only be interesting for 
understanding the RTX polymerase developed in Chapter 3, but will also aide in 
understanding how other replicative polymerase complexes make errors during genome 
replication.  
THE FUTURE OF POLYMERASE EVOLUTION 
 A growing field of interest is the use of synthetic nucleotide analogs, which have 
been shown to increase nucleic acid drug efficacy, increase stability, and even be used as 
a third base pair in a living organism (Malyshev and Romesberg, 2015). Unfortunately 
these fields have been stifled because polymerases do not use these bases readily, and 
often need to be engineered or have altered buffer conditions to polymerize effectively. In 
addition, highly modified nucleotides often need to be converted back to DNA in order to 
complete in vitro selection cycles which requires a reverse transcriptase that can make 
that conversion. With the evolution of RTX, RNA bases were programmed into the 
primer used during the selection, but other base analogs can be used in place of RNA. 
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This effectively shifts the selection pressure to enforce altered template utilization in the 
reverse transcription. The resulting polymerases gives a starting point for the evolution of 
biomolecules with nucleotide analogs in a more straightforward way, as selection 
approaches have gotten more clever at overcoming this problem (Kimoto et al., 2013; 
Sczepanski and Joyce, 2014). In addition, this may be a starting point for the generation 
of polymerases that utilize altered substrates throughout an entire PCR reaction.  
 Polymerases that especially adapted for use with the unnatural base pair (UBP) 
systems (Fig. C.3) (Malyshev et al., 2014; Thyer and Ellefson, 2014), may enable a more 
stable propagation in vivo. This has limited productivity in the field (personal 
communication) because they are quickly lost after the course of several replication 
events. This hinders further development of the biotechnology and the evolution using 
these systems. Tailor made polymerases that are friendlier to replication of UBPs may be 
achieved by using the RT-CSR technique. This may promote UBP use in diagnostic 
technologies and, although RT-CSR may not be capable of evolving the E. coli DNA 
polymerase, structural identification of residues which are more favorable to UBPs may 
be obtained.  
CONSIDERATIONS OF SELECTIONS 
 Through advancing these projects, critical parameters about how emulsions 
bubbles are formulated changed. In the initial CPR selections, the classic technique of 
using a stir bar spinning in oil - whilst aqueous was slowly added was used. This 
technique is very time consuming – especially for multiplexing selections, and was 
highly subject to variability depending on the volume of aqueous phage added over time. 
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This would result in variability between people: with better, more uniform, bubbles. 
Revisiting how emulsions were set up, we found that the emulsion bubbles used in the 
original CPR paper resulted in multiple E. coli inside each compartment (Fig. C.4). This 
should in theory greatly reduce the selection efficiency by allowing non-functional 
individuals to “tag along” with functional counterparts. Interestingly, the selections still 
worked. More rounds were possibly involved; as initially roughly eight rounds were 
turned for both the T7 RNA polymerase and tRNA selections, but they still worked and 
honed in on what were likely the best solutions. The process of setting up emulsions was 
greatly improved through the use of a tissuelyser (Qiagen) which shakes at specified 
frequencies. Whilst shaking, the emulsification is facilitated by the use of a nucleating 
structure - which in our case a 1 mL syringe plunger was most handy. These alterations 
made emulsion bubbles more uniform and most bubbles now contained only a single E. 
coli cell, as well as, making the process more highly throughput and consistent across 
individuals in the lab. While some speculation is required, this improved the selection 
efficiency such that in some cases large libraries (~107) could be selected in as little as 
three rounds of CPR. 
 Another important consideration about selections and library design was 
discovered during the repressor selection in Chapter 2. Whilst selecting for the OD 
binding repressor, the best variant contained a one amino acid deletion. This is surprising, 
as the winner of the selection contained an incredibly rare event that should technically 
not have happened. During oligonucleotide synthesis, -1 base deletions are somewhat 
common due to incomplete base incorporation. Within the oligonucleotide pool that was 
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use to construct the library (NNS randomization), three consecutive -1 deletions occurred 
within a short stretch, resulting in the deletion of an entire codon, in addition to 
containing the correct amino acid combination that would result in a tight binding 
repressor. The chances of this happening seem infinitesimally small and perhaps were 
selected because of pure luck. I think this speaks to a general misappreciation for how 
libraries are generally designed for directed evolution. The common practice for library 
design is to simply choose amino acids that are within proximity to the region of interest 
and do randomization of amino acids. Almost certainly as important as the amino acids 
themselves, is the positioning of residues around a target site by positioning of the 
backbone angles. The ability to not only randomize amino acids but also give more 
freedom to the angle at which they can interact with the target molecule is perhaps 
equally important. But how might this be remedied? Painstaking library design could in 
principle achieve this, by designing oligonucleotides that contain both randomization but 
also codon insertions and deletions. However this is problematic, as it greatly increases 
library design and complexity of the pool, as well as, financially being more expensive to 
construct. There are possible solutions to the practical synthesis of such complex 
libraries, which would not only randomize amino acids but positions. Oligonucletide 
libraries that are constructed on chips, either through electrochemical or photochemical 
synthesis protocols (Pike et al., 2002; Singh-Gasson et al., 1999), can create complex 
libraries not easily constructed from more traditional synthesis approaches. This is 
possible because each synthesized oligonucleotide is specified by inputting a file of 
sequences. Each synthesis location (~100,000) can be fully programmed to create an 
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oligonucleotide of exact sequence. While this is much more limited than traditional 
randomization, which can cover libraries roughly 1,000-fold bigger, it enables more 
complex libraries (such as indel libraries) to be created. Computer modeling and design 
of libraries can eliminate amino acids that will almost certainly not work in most binding 
pockets (e.g. tryptophan or proline) and redundancy of amino acid combinations found in 
NNS randomization. 
ALTERING THE FUNCTIONALITY OF THE FINAL COMPONENTS OF THE CENTRAL 
DOGMA 
 Some of the core features of the central dogma have been engineered as presented 
in this dissertation (Fig. C.5). In Chapter 1, the genetic code was altered not only by 
reassignment of codons (shifting the amber codon from a stop codon to a tryptophan or 
tryptophan analog), but also by the incorporation of a nonstandard amino acid, 5-
hydroxy-L-tryptophan. In both Chapters 1 and 2, the regulation of transcription was 
engineered by selecting the T7 RNA polymerase, as well as, the tryptophan repressor. In 
Chapter 3, the first proofreading reverse transcriptase was created from an Archaeal DNA 
polymerase. This polymerase can convert RNA to DNA, DNA to DNA, and even O-
methyl RNA to DNA.  
 These efforts are not only useful research tools for other scientists in the field, but 
also demonstrate a more profound concept – even the oldest and most evolutionarily 
conserved cellular processes can be vastly altered given the right evolutionary paradigm. 
The components of the central dogma are plastic and can be altered to give wildly 
different functions. This may be surprising or unsurprising – of course biological 
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complexes could have different function! Researchers have shown this time and time 
again, with a wide array of molecules. Even molecules without much chemical diversity, 
like nucleotide polymers, can be coaxed into performing all sorts of functions. Perhaps 
the ability to engineer the central dogma is surprising simply because it has been quite 
difficult. It is so deeply entrenched in the biology, that finding selection conditions to 
allow probing of its components is especially tricky.  
 While headway has been made herein this dissertation to engineering the central 
dogma, several components were not covered. While T7 RNA polymerase was 
engineered to recognize different promoter sequences, this would not technically be an 
alteration of the genetic code. A true modification of the genetic code relies on altering 
the informational flow by changing the molecular composition of the RNA molecule. 
While there are a number of known modifications known to alter T7 RNA polymerase 
substrate specificity, the high throughput search through sequence space has been 
hampered by the lack of an in vitro or in vivo selection for incorporation of nucleotide 
triphosphate analogs. RNA polymerases that can incorporate modified nucleotides 
efficiently would have broad implications, as they are useful for therapeutic drug 
development. But more interestingly, they do not require a primer to initiate 
polymerization (like the discussed DNA polymerases in Chapter 3) which gives them the 
unique ability to operate in vivo given a cognate promoter sequence.  
 The last feature of the central dogma, and likely the toughest challenge, is the 
reengineering of the ribosome. The ribosome is so complicated to engineer because, 
unlike other components, it is incredibly integrated. The biosynthesis pathway  is highly 
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regulated at every level: post-transcriptional modifications to RNA, many associated and 
integral proteins, translation being tightly regulated by a host of enzymes, etc. 
(Kaczanowska and Ryden-Aulin, 2007). Minor alterations can have significant effects, as 
so many parts come together to form the whole. Despite this complexity, some headway 
has been made towards engineering a ribosome that can utilize alternative chemistries. 
Prokaryotic ribosomes have been engineered with various anti-Shine Dalgarno 
sequences, allowing binding and translation initiation of orthogonal RBS sequences 
(Rackham and Chin, 2005). In recent work, a “tethered” ribosome was created by a 
fusion of the 16S and 23S subunits – making the large and small subunits a single 
contiguous transcript (Orelle et al., 2015). This is significant because unlike orthogonal 
ribosomes (altered 16S anti-RBS) this allows modifications to the large subunit which 
contains the peptidyl transferase active site. Mutations to the tRNA entry site or the 
peptidyl transferase would almost certainly be lethal to E. coli cells, but the ability to 
have an orthogonal ribosome working in parallel with the host ribosome would allow 
modifications and probing of the function of the ribosome. This could enable mutations 
that increase unnatural amino acid incorporation, or even allow the polymerization of 
functional groups other than carboxyl-amine bonds.  
 As integral parts of the central dogma are reengineered with novel functionalities, 
and tools are developed in parallel to further modify them – there will be a push towards 
creating life forms that have an entirely orthogonal central dogma. The hereditary 
polymer, the messenger, and the protein components will be distinct from life as it 
currently is. The chemically orthogonal nature of these molecules, and perhaps 
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organisms, can allow the creation of diagnostic and therapeutic tools that are beyond the 




Figure C.1 : First representation of the CPR scheme 
The CPR scheme was originally intended to explore the functional consequences of an 
expanded genetic code on polymerase evolution. However, the diagram also depicted a 





Figure C.2 : Evolved biosensors can be used for the CPR evolution of metabolism 
The directed evolution of a biosensor enables CPR selection based on the intracellular 
concentration of the signal molecule. This can be used for the evolution of single 




Figure C.3 : Unnatural base pairs expand cellular functions 
Unnatural base pair (UBP) systems have the potential to expand a number of cellular 
systems. Several UBP systems have been described which can potentially be transported 
into the cell and replicated via endogenous machinery. Transcription of the UBPs could 




Figure C.4 : Optimization of emulsion setup 
Initial emulsions were created by the shear forces generated by a spinning magnetic bar. 
These resulted in emulsion bubbles of various sizes which contained a number of 
bacteria. The emulsion parameters were altered to use a tissuelyser, which improved 




Figure C.5 : Evolution of the central dogma using emulsion based directed evolution 
The methods and techniques developed in this dissertation have allowed the engineering 
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